Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
102000,,active,6583669,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1486752,,7,1,,,Potency,nM,,2133.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,2.1331
102001,,inconclusive,6662678,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1300220,,7,1,,,Potency,nM,,18526.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,18.526
102002,,inconclusive,7135671,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1300220,,7,1,,,Potency,nM,,1471.6,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,1.4716
102003,,active,7163470,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1486752,,7,1,,,Potency,nM,,1510.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,1.5101
102004,,inconclusive,7325627,[],CHEMBL1794308,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1309187,,7,1,,,Potency,nM,,1834.9,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,Potency,uM,UO_0000065,,1.8349
102005,,inconclusive,7431694,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1520514,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102006,,inconclusive,7438001,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1507136,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102007,,inconclusive,7438643,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1010789,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102008,,inconclusive,7442651,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1507375,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102009,,inconclusive,7463443,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,977609,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102010,,inconclusive,7480806,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1507137,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102011,,inconclusive,7481581,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1300220,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102012,,inconclusive,7481683,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1391023,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102013,,inconclusive,7487879,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1309187,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102014,,inconclusive,7489326,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1519697,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102015,,inconclusive,7507331,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1529822,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102016,,inconclusive,7510721,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,979157,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102017,,inconclusive,7538271,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1486752,,7,1,,,Potency,nM,,819.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.8196
102018,,,7566404,[],CHEMBL1908285,Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1539112,=,1,0,=,,Papp,nm/s,,73.9,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,73.9
102019,,,7566470,[],CHEMBL1908286,Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1539112,=,1,0,=,,Papp,nm/s,,267.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,267.0
102020,,Effluxed: Y,7566536,[],CHEMBL1908289,Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1539112,=,1,0,=,,Ratio_Papp,,,3.61,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_Papp,,,,3.61
102021,,ATPase Activator: Y,7566596,[],CHEMBL1908291,Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM,B,,,BAO_0000179,BAO_0000249,cell membrane format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1539112,=,1,0,=,,Ratio_ATPase activity,,,3.61,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_ATPase activity,,,,3.61
102022,,Calcein-AM Inhibitor: N,7566656,[],CHEMBL1908292,Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay,B,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1539112,=,1,0,=,,% maximum response,%,,1.35,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,% maximum response,%,UO_0000187,,1.35
102023,,,7830777,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
102024,,,7830778,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
102025,,,7830779,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
102026,,,7830780,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
102027,,,7830781,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
102028,,,7830782,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_hepatic failure,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,0.0
102029,,,7830783,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
102030,,,7830784,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_hepatitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,0.0
102031,,,7830785,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
102032,,,7830786,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
102033,,,7830787,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
102034,,,7830788,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
102035,,,7830789,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
102036,,,7830790,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1540703,=,1,0,=,,HepSE_Combined Scores,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,1.0
102037,,,10843688,[],CHEMBL2016359,"Antimicrobial activity against ciprofloxacin-, SXT-sensitive Escherichia coli ATCC 25922",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
102038,,,10843689,[],CHEMBL2016360,"Antimicrobial activity against ciprofloxacin-sensitive, SXT-resistant Klebsiella pneumoniae ATCC 700603",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
102039,,,10843690,[],CHEMBL2016361,"Antimicrobial activity against ciprofloxacin-sensitive, SXT-resistant Pseudomonas aeruginosa ATCC 10145",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
102040,,,10843691,[],CHEMBL2016362,"Antimicrobial activity against ciprofloxacin-, SXT-resistant Escherichia coli",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
102041,,,10843692,[],CHEMBL2016363,"Antimicrobial activity against ciprofloxacin-, SXT-sensitive Staphylococcus aureus ATCC 25923",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102042,,,10843693,[],CHEMBL2016364,"Antimicrobial activity against ciprofloxacin-sensitive, SXT-resistant Staphylococcus epidermidis NRS60",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1633601,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
102043,,Not Determined,10843694,[],CHEMBL2016365,Inhibition of DNA supercoiling activity of Escherichia coli DNA gyrase after 1 hr by agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1633601,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102044,,Not Determined,10843695,[],CHEMBL2016366,Inhibition of DNA decatenation activity of Escherichia coli DNA topoisomerase 4 after 1 hr by agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1633601,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102045,,,10843696,[],CHEMBL2016367,Inhibition of DHFR using dihydrofolate as substrate following 3 mins substrate preincubation measured after 3 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2010671,Bioorg Med Chem Lett,2012.0,"{'bei': '23.80', 'le': '0.45', 'lle': '5.65', 'sei': '6.55'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.91,0,http://www.openphacts.org/units/Nanomolar,1633601,=,1,1,=,,IC50,nM,,123.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,uM,UO_0000065,,0.123
102046,,,10850876,[],CHEMBL2020020,Antiparasitic activity against Toxoplasma gondii ATCC 50839 infected in human fibroblasts assessed as inhibition of replication of tachyzoites after 4 days by bacterial beta-galactosidase assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2016442,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,1635951,=,1,0,=,,ID50,uM,,15.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,ID50,uM,UO_0000064,,15.0
102047,,,10850889,[],CHEMBL2020021,Cytotoxicity against human fibroblasts assessed as cell viability by microplate reader,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2016442,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,1635951,>,1,0,>,,TD50,uM,,500.0,CHEMBL612558,,ADMET,,,,TD50,uM,UO_0000064,,500.0
102048,,,10850902,[],CHEMBL2020022,"Therapeutic index, ratio of TD50 for human fibroblast cell to ID 50 for Toxoplasma gondii ATCC 50839",A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2016442,Bioorg Med Chem Lett,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1635951,>,1,0,>,,TI,,,3.0,CHEMBL612558,,ADMET,,,,TI,,,,3.0
102049,,,10925193,[],CHEMBL2045683,"Selectivity index, ratio of binding affinity to human DHFR to binding affinity to Escherichia coli DHFR",B,,,BAO_0002136,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2040719,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1649784,=,1,0,=,,Selectivity ratio,,,4.0,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,4.0
102050,,,10925194,[],CHEMBL2045684,Selectivity ratio of Ki for chromosomal DHFR to Ki for R67 DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2040719,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1649784,>,1,0,>,,Ratio Ki,,,1000000.0,CHEMBL612545,,Unchecked,,,,Ratio Ki,,,,1000000.0
102051,,,10925195,[],CHEMBL2045685,Selectivity ratio of IC50 for chromosomal DHFR to IC50 for R67 DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2040719,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1649784,>,1,0,>,,Ratio IC50,,,1000000.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,1000000.0
102052,,,10944801,[],CHEMBL2050303,Inhibition of Escherichia coli DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Potential transcription error,"Values appear to be an order of magnitude different from previously reported, so units may be incorrect",CHEMBL2046359,Bioorg Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/Nanomolar,1652302,=,1,1,=,,IC50,nM,,10.0,CHEMBL1809,Escherichia coli,Dihydrofolate reductase,562.0,,,IC50,10'-8M,UO_0000065,,1.0
102053,,,10944809,[],CHEMBL2050302,Inhibition of human DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2046359,Bioorg Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/Nanomolar,1652302,>,1,1,>,,IC50,nM,,340000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,10'-4M,UO_0000065,,3.4
102054,,,10944976,[],CHEMBL2050304,Inhibition of Toxoplasma gondii DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2046359,Bioorg Med Chem,2012.0,"{'bei': '17.80', 'le': '0.34', 'lle': '3.91', 'sei': '4.90'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.17,1,http://www.openphacts.org/units/Nanomolar,1652302,=,1,1,=,,IC50,nM,,6800.0,CHEMBL2425,Toxoplasma gondii,Dihydrofolate reductase,5811.0,,,IC50,uM,UO_0000065,,6.8
102055,,Active,10983239,[],CHEMBL2071965,Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Inhibition,%,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,INH,,UO_0000187,,
102056,,Active,10984071,[],CHEMBL2071964,Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Inhibition,%,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,INH,,UO_0000187,,
102057,,Active,10984292,[],CHEMBL2071963,Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Inhibition,%,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,INH,,UO_0000187,,
102058,,Active,10985115,[],CHEMBL2071962,Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Inhibition,%,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,INH,,UO_0000187,,
102059,,Not Determined,10986617,[],CHEMBL2071972,Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH,A,,,BAO_0000375,BAO_0000251,microsome format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1663628,,1,0,,,Activity,,,,CHEMBL613373,Homo sapiens,Liver microsomes,9606.0,,,Activity,,,,
102060,,Stable,10995291,[],CHEMBL2071971,Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis,A,,,BAO_0000179,BAO_0000251,microsome format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Stability,%,,,CHEMBL613373,Homo sapiens,Liver microsomes,9606.0,,,Stability,,UO_0000187,,
102061,,Active,10995483,[],CHEMBL2071967,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1663628,,1,0,,,Inhibition,%,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,INH,,UO_0000187,,
102062,,,10996601,[],CHEMBL2071966,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins,A,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1663628,<,1,0,<,,Ratio IC50,,,2.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ratio IC50,,,,2.0
102063,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",substrate [+],10997704,[],CHEMBL2076217,TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1671559,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
102064,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",substrate [+],10997761,[],CHEMBL2076219,TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1671559,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
102065,,is not an inducer [-],11001213,[],CHEMBL2078152,TP_TRANSPORTER: RT-PCR in HK-2 cell,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2074170,Toxicol Appl Pharmacol,2002.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1671273,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
102066,,is not an inducer [-],11001217,[],CHEMBL2076047,"TP_TRANSPORTER: Western blot, HK-2 cells",F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2074170,Toxicol Appl Pharmacol,2002.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1671273,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
102067,,is not an inhibitor [-],11001549,[],CHEMBL2076208,TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1671559,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
102068,,inactive,11477988,[],CHEMBL2114744,PubChem BioAssay. HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1309187,,7,1,,,Potency,nM,,23.1,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Potency,uM,UO_0000065,,0.0231
102069,,inactive,11610748,[],CHEMBL2114780,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1519697,,7,1,,,Potency,nM,,1584.9,CHEMBL1293278,Homo sapiens,Geminin,9606.0,,,Potency,uM,UO_0000065,,1.5849
102070,,inconclusive,11948319,[],CHEMBL2114835,PubChem BioAssay. qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1010789,,7,1,,,Potency,nM,,74978.0,CHEMBL2157,Homo sapiens,Interleukin-8,9606.0,,,Potency,uM,UO_0000065,,74.978
102071,,Not Active,12089030,[],CHEMBL2168664,Growth inhibition of human NCI60 cells at 10 uM incubated for 48 hrs by SRB assay,F,,,BAO_0000181,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2163263,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1735757,,1,0,,,GI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI,,,,
102072,,,12089556,[],CHEMBL2169431,Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1736677,=,1,1,=,,Inhibition,%,,35.1,CHEMBL1743124,Homo sapiens,Solute carrier organic anion transporter family member 2B1,9606.0,,,INH,%,UO_0000187,,35.1
102073,,,12089779,[],CHEMBL2169430,Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1736677,=,1,1,=,,Inhibition,%,,18.8,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,INH,%,UO_0000187,,18.8
102074,,,12090591,[],CHEMBL2169429,Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1736677,=,1,1,=,,Inhibition,%,,24.7,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,INH,%,UO_0000187,,24.7
102075,,,12414006,[],CHEMBL3047052,Antifungal activity against Candida parapsilosis NRRL Y-12969 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL612868,Candida parapsilosis,Candida parapsilosis,5480.0,,,MIC,ug ml-1,UO_0000274,,12.5
102076,,,12414007,[],CHEMBL3047053,Antifungal activity against Candida zeylanoides NRRL Y-1774 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612310,[Candida] zeylanoides,[Candida] zeylanoides,5493.0,,,MIC,ug ml-1,UO_0000274,,25.0
102077,,,12414008,[],CHEMBL3047054,Antifungal activity against Pichia kudriavzevii NRRL Y-7179 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612841,Pichia kudriavzevii,Pichia kudriavzevii,4909.0,,,MIC,ug ml-1,UO_0000274,,25.0
102078,,,12414009,[],CHEMBL3047055,Antifungal activity against Candida tropicalis NRRL Y-12968 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,25.0
102079,,,12414010,[],CHEMBL3047056,Antifungal activity against Cyberlindnera jadinii NRRL Y-900 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,,MIC,ug ml-1,UO_0000274,,25.0
102080,,,12414011,[],CHEMBL3047057,Antifungal activity against Candida glabrata clinical isolate after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612647,Nakaseomyces glabratus,Nakaseomyces glabratus,5478.0,,,MIC,ug ml-1,UO_0000274,,25.0
102081,,,12414012,[],CHEMBL3047058,Antifungal activity against Candida glabrata ATCC 36583 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL612647,Nakaseomyces glabratus,Nakaseomyces glabratus,5478.0,,,MIC,ug ml-1,UO_0000274,,50.0
102082,,,12414013,[],CHEMBL3047059,Antifungal activity against Candida albicans clinical isolate after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,12.5
102083,,,12414014,[],CHEMBL3047060,Antifungal activity against Candida albicans NRRL Y-27077 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,50.0
102084,,,12414015,[],CHEMBL3047061,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,50.0
102085,,,12414016,[],CHEMBL3047062,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
102086,,,12414017,[],CHEMBL3047063,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,50.0
102087,,,12414018,[],CHEMBL3047064,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhimurium NRRL B-4420 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,50.0
102088,,,12414019,[],CHEMBL3047065,Antibacterial activity against Proteus vulgaris NRLL B-123 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,50.0
102089,,,12414020,[],CHEMBL3047066,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,50.0
102090,,,12414021,[],CHEMBL3047067,Antibacterial activity against Escherichia coli ATCC 35218 after 24 to 48 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046102,Med Chem Res,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1798389,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
102091,,,12432167,[],CHEMBL3066823,"Apparent hydrophobicity, log D of the compound in Octanol-buffer",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1803238,=,1,1,=,,LogD,,,0.91,CHEMBL2362975,,No relevant target,,,,logD(app),,,,0.91
102092,,,12432221,[],CHEMBL3066822,"Dissociation constant, pKa of the compound at pH 7.3",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1803238,=,1,0,=,,pKa,,,0.0,CHEMBL2362975,,No relevant target,,,,pKa,,,,0.0
102093,,,12432275,[],CHEMBL3066824,Apparent permeability of the compound by PAMPA,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1803238,=,1,0,=,,logPapp,,,-5.5,CHEMBL2362975,,No relevant target,,,,logPapp,,,,-5.5
102094,,,12432349,[],CHEMBL3066825,"Hydrophobicity, log P of the compound in octanol-water by shaking-flask method",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1803238,=,1,1,=,,LogP,,,0.91,CHEMBL2362975,,No relevant target,,,,logP,,,,0.91
102095,,,12472612,[],CHEMBL3056824,Inhibition of Homo sapiens (human) dihydrofolate reductase using dihydrofolate as substrate incubated for 5 min prior to substrate addition by spectrophotometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3045961,Med Chem Res,2008.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,1808430,=,1,1,=,,IC50,nM,,890000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,uM,UO_0000065,,890.0
102096,,,12472624,[],CHEMBL3056825,Inhibition of Cryptosporidium parvum recombinant DHFR using dihydrofolate as substrate incubated for 5 min prior to substrate addition by spectrophotometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3045961,Med Chem Res,2008.0,"{'bei': '18.59', 'le': '0.35', 'lle': '4.14', 'sei': '5.12'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.4,0,http://www.openphacts.org/units/Nanomolar,1808430,=,1,1,=,,IC50,nM,,4000.0,CHEMBL2366489,Cryptosporidium parvum,Bifunctional dihydrofolate reductase-thymidylate synthase,5807.0,,,IC50,uM,UO_0000065,,4.0
102097,,,12533251,[],CHEMBL3084009,Antibacterial activity against Bacillus subtilis ATCC 6633 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,20.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,20.0
102098,,,12533252,[],CHEMBL3084011,Antibacterial activity against Enterococcus faecalis ATCC 29212 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,27.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,27.0
102099,,,12533253,[],CHEMBL3084010,Antibacterial activity against Bacillus cereus ATCC 11778 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,0.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,DIZ,mm,UO_0000016,,0.0
102100,,,12533254,[],CHEMBL3084012,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,37.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,37.0
102101,,,12533255,[],CHEMBL3084013,Antifungal activity against Candida albicans ATCC 90028 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,0.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,DIZ,mm,UO_0000016,,0.0
102102,,,12533256,[],CHEMBL3084015,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,31.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,31.0
102103,,,12533257,[],CHEMBL3084016,Antibacterial activity against Escherichia coli ATCC 25922 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,0.0
102104,,,12533258,[],CHEMBL3084017,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,0.0
102105,,,12533259,[],CHEMBL3084019,Antibacterial activity against Pseudomonas fluorescens ATCC 49838 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,0.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,DIZ,mm,UO_0000016,,0.0
102106,,,12533260,[],CHEMBL3084018,Antibacterial activity against Enterobacter aerogenes ATCC 13048 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,28.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,DIZ,mm,UO_0000016,,28.0
102107,,,12533261,[],CHEMBL3084020,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 at 30 ug/disk after 18 to 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,1826124,=,1,1,=,,IZ,mm,,29.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,DIZ,mm,UO_0000016,,29.0
102108,,,12533262,[],CHEMBL3076347,Antifungal activity against Candida albicans ATCC 90028 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,0.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,0.0
102109,,,12533263,[],CHEMBL3076348,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
102110,,,12533264,[],CHEMBL3076349,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0
102111,,,12533265,[],CHEMBL3076350,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
102112,,,12533266,[],CHEMBL3076351,Antibacterial activity against Pseudomonas fluorescens ATCC 49838 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,1.0
102113,,,12533267,[],CHEMBL3076352,Antibacterial activity against Enterobacter aerogenes ATCC 13048 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,1.0
102114,,,12533268,[],CHEMBL3076353,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.0
102115,,,12533269,[],CHEMBL3084081,Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
102116,,,12533270,[],CHEMBL3076364,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
102117,,,12533271,[],CHEMBL3076365,Antibacterial activity against Bacillus cereus ATCC 11778 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,0.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.0
102118,,,12533272,[],CHEMBL3076366,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3044670,Med Chem Res,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826124,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102119,,,12614429,[],CHEMBL2317807,"Therapeutic index, ratio of TD50 for human foreskin fibroblast cells to ID 50 for Toxoplasma gondii",A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2311382,Bioorg Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1845164,>,1,0,>,,TI,,,3.0,CHEMBL612558,,ADMET,,,,TI,,,,3.0
102120,,,12614448,[],CHEMBL2317808,Cytotoxicity against human foreskin fibroblast cells by colorimetric method,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2311382,Bioorg Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,1845164,>,1,0,>,,TD50,uM,,100.0,CHEMBL614071,Homo sapiens,HFF,9606.0,,,TD50,uM,UO_0000064,,100.0
102121,,,12614467,[],CHEMBL2317809,Antimicrobial activity against Toxoplasma gondii assessed as inhibition of growth measured after 5 days by beta-galactosidase assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2311382,Bioorg Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,1845164,=,1,0,=,,ID50,uM,,15.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,ID50,uM,UO_0000064,,15.0
102122,,Not Active,13292920,[],CHEMBL2379855,Antibacterial activity against Escherichia coli EB2120 conditional lolA strain with lolA deletion and complementing copy placed at araBAD locus at 1 to 256 ug/mL after 18 hrs in presence of 0.00002 to 0.2% of arabinose,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2375351,Bioorg Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1890970,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
102123,,,13297216,[],CHEMBL2384158,Selectivity ratio of IC50 for rat liver DHFR to IC50 for Pneumocystis carinii DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1895099,=,1,0,=,,Ratio IC50,,,14.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,14.0
102124,,,13297244,[],CHEMBL2384160,Selectivity ratio of IC50 for rat liver DHFR to IC50 for Mycobacterium avium DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1895099,=,1,0,=,,Ratio IC50,,,120000.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,120000.0
102125,,,13297272,[],CHEMBL2384159,Inhibition of Mycobacterium avium DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.82,0,http://www.openphacts.org/units/Nanomolar,1895099,=,1,1,=,,IC50,nM,,1.5,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.0015
102126,,,13297300,[],CHEMBL2384162,Inhibition of rat liver DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/Nanomolar,1895099,=,1,1,=,,IC50,nM,,180000.0,CHEMBL2363,Rattus norvegicus,Dihydrofolate reductase,10116.0,,,IC50,uM,UO_0000065,,180.0
102127,,,13297328,[],CHEMBL2384161,Inhibition of Pneumocystis carinii DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,"{'bei': '16.89', 'le': '0.32', 'lle': '3.64', 'sei': '4.65'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.9,0,http://www.openphacts.org/units/Nanomolar,1895099,=,1,1,=,,IC50,nM,,12500.0,CHEMBL1926,Pneumocystis carinii,Dihydrofolate reductase,4754.0,,,IC50,uM,UO_0000065,,12.5
102128,,,13297356,[],CHEMBL2384163,Selectivity ratio of IC50 for human recombinant DHFR to IC50 for Pneumocystis jirovecii recombinant DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1895099,=,1,0,=,,Ratio IC50,,,268.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,268.0
102129,,,13297384,[],CHEMBL2384165,Inhibition of human recombinant DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,"{'bei': '15.47', 'le': '0.29', 'lle': '3.23', 'sei': '4.26'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.49,0,http://www.openphacts.org/units/Nanomolar,1895099,=,1,1,=,,IC50,nM,,32200.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,uM,UO_0000065,,32.2
102130,,,13297412,[],CHEMBL2384164,Inhibition of Pneumocystis jirovecii recombinant DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL2380288,J Med Chem,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.92,0,http://www.openphacts.org/units/Nanomolar,1895099,=,1,1,=,,IC50,nM,,120.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.12
102131,,,13799683,[],CHEMBL3039488,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1937024,=,1,1,=,,Inhibition,%,,82.92,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,Inhibition,%,UO_0000187,,82.916018
102132,,,13801682,[],CHEMBL3039491,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1937024,=,1,1,=,,Inhibition,%,,97.26,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,Inhibition,%,UO_0000187,,97.2610178
102133,,,13860925,[],CHEMBL3101462,Selectivity ratio of IC50 for human DHFR to IC50 for Toxoplasma gondii DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3098035,ACS Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1956371,=,1,0,=,,Ratio IC50,,,49.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,49.0
102134,,,13860926,[],CHEMBL3101463,Inhibition of Toxoplasma gondii DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3098035,ACS Med Chem Lett,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.57,0,http://www.openphacts.org/units/Nanomolar,1956371,=,1,1,=,,IC50,nM,,2700.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,2.7
102135,,,13939371,[],CHEMBL3130225,Inhibition of human DHFR using dihydrofolate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis in presence of NADPH,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,"{'bei': '16.26', 'le': '0.31', 'lle': '3.46', 'sei': '4.47'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.72,1,http://www.openphacts.org/units/Nanomolar,1974159,=,1,1,=,,Ki,nM,,19070.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Ki,nM,UO_0000065,,19070.0
102136,,,13939400,[],CHEMBL3130226,Inhibition of Staphylococcus aureus DHFR using dihydrofolate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis in presence of NADPH,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,"{'bei': '30.73', 'le': '0.58', 'lle': '7.66', 'sei': '8.45'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.92,1,http://www.openphacts.org/units/Nanomolar,1974159,=,1,1,=,,Ki,nM,,1.2,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,1.2
102137,,,13963186,[],CHEMBL3130203,Antibacterial activity against Streptococcus pneumoniae after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,64.0
102138,,,13963191,[],CHEMBL3130203,Antibacterial activity against Streptococcus pneumoniae after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
102139,,,13963204,[],CHEMBL3130210,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-255 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
102140,,,13963210,[],CHEMBL3130211,Antibacterial activity against Streptococcus pneumoniae ATCC 700904 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
102141,,,13963216,[],CHEMBL3130212,Antibacterial activity against Streptococcus pneumoniae ATCC 700676 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
102142,,,13963222,[],CHEMBL3130213,Antibacterial activity against Streptococcus pneumoniae ATCC 700677 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
102143,,,13963228,[],CHEMBL3130214,Antibacterial activity against Streptococcus pneumoniae ATCC 700675 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
102144,,,13963234,[],CHEMBL3130215,Antibacterial activity against Streptococcus pneumoniae ATCC 51916 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
102145,,,13963240,[],CHEMBL3130216,Antibacterial activity against Streptococcus pneumoniae ATCC 700671 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
102146,,,13963246,[],CHEMBL3130217,Antibacterial activity against Streptococcus pneumoniae ATCC 700669 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
102147,,,13963252,[],CHEMBL3130218,Antibacterial activity against Streptococcus pneumoniae ATCC 700674 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
102148,,,13963258,[],CHEMBL3130219,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
102149,,,13963287,[],CHEMBL3130221,Antibacterial activity against TMP-resistant Staphylococcus aureus expressing DHFR F99Y mutant after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
102150,,,13963315,[],CHEMBL3130222,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 18 to 24 hrs by alamar Blue assay in presence of 20% heat inactivated mouse serum,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102151,,,13963343,[],CHEMBL3130223,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 18 to 24 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974159,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102152,,,13963372,[],CHEMBL3130224,Selectivity ratio of Ki for human DHFR to Ki for Staphylococcus aureus DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3124778,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1974159,=,1,0,=,,Ratio Ki,,,15400.0,CHEMBL612545,,Unchecked,,,,Ratio Ki,,,,15400.0
102153,,references out of a total of 6,13994997,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (moderate),,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,1.0
102154,,,13994998,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1980186,=,1,0,=,,Hepatotoxicity (moderate),%,,5.9,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,5.9
102155,,references out of a total of 6,13994999,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (acute),,,6.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,6.0
102156,,,13995000,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,1980186,=,1,0,=,,Hepatotoxicity (acute),%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,0.0
102157,,references out of a total of 6,13995001,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (cytolytic),,,2.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,2.0
102158,,references out of a total of 6,13995002,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (choleostasis),,,5.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,5.0
102159,,references out of a total of 6,13995003,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,1.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,1.0
102160,,references out of a total of 6,13995004,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
102161,,references out of a total of 6,13995005,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
102162,,references out of a total of 6,13995006,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
102163,,references out of a total of 6,13995007,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
102164,,references out of a total of 6,13995008,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
102165,,references out of a total of 6,13995009,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
102166,,references out of a total of 6,13995010,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
102167,,,13995011,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
102168,,yes,13995012,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
102169,,,13995013,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
102170,,5 days - 24 days,13995014,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
102171,,,13995015,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,1980186,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
102172,,active,14304203,[],CHEMBL3215291,PubChem BioAssay. qHTS profiling of Chloroquine Analogs as inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2038379,,7,1,,,Potency,nM,,4213.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Potency,uM,UO_0000065,,4.2135
102173,,inconclusive,14323854,[],CHEMBL3215270,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2045227,,7,1,,,Potency,nM,,5011.9,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,5.0119
102174,,inactive,14440596,[],CHEMBL3214892,PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2038379,,7,1,,,Potency,nM,,9432.9,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Potency,uM,UO_0000065,,9.4329
102175,,,14539313,[],CHEMBL3227821,Inhibition of Bacillus anthracis DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.11,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,77000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,77.0
102176,,,14539314,[],CHEMBL3227822,Inhibition of Candida albicans DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,"{'bei': '15.11', 'le': '0.29', 'lle': '3.13', 'sei': '4.16'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.39,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,41000.0,CHEMBL2329,Candida albicans,Dihydrofolate reductase,5476.0,,,IC50,uM,UO_0000065,,41.0
102177,,,14539315,[],CHEMBL3227823,Inhibition of Candida glabrata DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.16,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,7000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,7.0
102178,,,14539316,[],CHEMBL3227824,Inhibition of Cryptosporidium hominis DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.85,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,14000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,14.0
102179,,,14539317,[],CHEMBL3227825,Inhibition of methicillin-resistant Staphylococcus aureus DHFR,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,"{'bei': '26.31', 'le': '0.50', 'lle': '6.38', 'sei': '7.24'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.64,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,23.0,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,IC50,nM,UO_0000065,,23.0
102180,,,14539318,[],CHEMBL3227826,Inhibition of methicillin-resistant Staphylococcus aureus DHFR F98Y mutant,B,P0A017,F99Y,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,"{'bei': '19.87', 'le': '0.38', 'lle': '4.51', 'sei': '5.47'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.77,0,http://www.openphacts.org/units/Nanomolar,2074728,=,1,1,=,,IC50,nM,,1700.0,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,IC50,uM,UO_0000065,,1.7
102181,,,14539319,[],CHEMBL3227827,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2074728,=,1,1,=,,MIC,ug.mL-1,,0.62,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.62
102182,,,14539320,[],CHEMBL3227828,Antibacterial activity against Bactrim-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2074728,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
102183,,,14539321,[],CHEMBL3227829,Ratio of IC50 for methicillin-resistant Staphylococcus aureus DHFR F98Y mutant to IC50 for methicillin-resistant Staphylococcus aureus DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3217444,Medchemcomm,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2074728,=,1,0,=,,Ratio IC50,,,74.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,74.0
102184,,,14561877,[],CHEMBL3231328,Inhibition of bovine liver dihydrofolate reductase using dihydrofolic acid as substrate,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3227947,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2079823,=,1,0,=,,log(1/I50),,,5.1,CHEMBL1075051,Bos taurus,Dihydrofolate reductase,9913.0,,,log(1/I50),,,,5.1
102185,,,14623221,[],CHEMBL3254812,Antibacterial activity against Streptococcus faecalis MGH2 assessed as growth inhibition by Gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2094742,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
102186,,,14623230,[],CHEMBL3254813,Antibacterial activity against Staphylococcus aureus UC-76 assessed as growth inhibition by Gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2094742,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102187,,,14623239,[],CHEMBL3254814,Antibacterial activity against drug-resistant Staphylococcus aureus S18713 assessed as growth inhibition by Gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2094742,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102188,,Not Active,14623248,[],CHEMBL3254815,Antibacterial activity against Pseudomonas aeruginosa 28 by Gradient plate test,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2094742,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
102189,,Not Active,14623257,[],CHEMBL3254816,Antibacterial activity against Escherichia coli Vogel by Gradient plate test,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2094742,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
102190,,Not Active,14623266,[],CHEMBL3254817,Antibacterial activity against Shigella sonnei C-10 by Gradient plate test,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244140,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2094742,,1,0,,,Activity,,,,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,Activity,,,,
102191,,,14623502,[],CHEMBL3254073,Antibacterial activity against Streptococcus faecalis MGH-2 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
102192,,,14623503,[],CHEMBL3254074,Antibacterial activity against Staphylococcus aureus UC-76 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102193,,,14623504,[],CHEMBL3254075,Antibacterial activity against Staphylococcus aureus S18713 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102194,,,14623505,[],CHEMBL3254076,Antibacterial activity against Pseudomonas aeruginosa 28 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,25.0
102195,,,14623506,[],CHEMBL3254077,Antibacterial activity against Escherichia coli Vogel assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
102196,,,14623507,[],CHEMBL3254078,Antibacterial activity against Shigella sonnei C-10 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.25
102197,,,14623508,[],CHEMBL3254079,Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3244272,J Med Chem,1979.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2090793,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,25.0
102198,,,14679166,[],CHEMBL3282589,"Fold increase in resistance, ratio of IC50 for chlorguanide triazine-resistant Streptococcus faecium ATCC 8043 to IC50 for sensitive Streptococcus faecium ATCC 8043",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2104920,=,1,0,=,,Ratio IC50,,,15.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Ratio IC50,,,,15.0
102199,,,14679199,[],CHEMBL3282590,Antibacterial activity against sensitive Lactobacillus casei ATCC 7469 assessed as reduction,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.72,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,190.0,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,IC50,uM,UO_0000065,,0.19
102200,,,14679239,[],CHEMBL3282591,Antibacterial activity against chlorguanide triazine-resistant Lactobacillus casei ATCC 7469 assessed as reduction in growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.77,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,17.0,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,IC50,uM,UO_0000065,,0.017
102201,,,14679279,[],CHEMBL3285741,"Fold increase in resistance, ratio of IC50 for chlorguanide triazine-resistant Lactobacillus casei ATCC 7469 to IC50 for sensitive Lactobacillus casei ATCC 7469",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2104920,=,1,0,=,,Ratio IC50,,,0.09,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,Ratio IC50,,,,0.09
102202,,,14679316,[],CHEMBL3285742,Antibacterial activity against sensitive Pediococcus cerevisiae ATCC 808 assessed as reduction,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.93,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,11700.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,11.7
102203,,,14679356,[],CHEMBL3285743,Antibacterial activity against chlorguanide triazine-resistant Pediococcus cerevisiae ATCC 808 assessed as reduction in growth,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.17,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,67500.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,67.5
102204,,,14679396,[],CHEMBL3285744,"Fold increase in resistance, ratio of IC50 for chlorguanide triazine-resistant Pediococcus cerevisiae ATCC 808 to IC50 for sensitive Pediococcus cerevisiae ATCC 808",F,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2104920,=,1,0,=,,Ratio IC50,,,6.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,6.0
102205,,,14679429,[],CHEMBL3285745,Antibacterial activity against sensitive Escherichia coli ATCC 10536 assessed as reduction in growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.4,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,0.4
102206,,,14682195,[],CHEMBL3285706,Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as daily dose required to suppression of 90% parasite infection administered with diet for 6 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2105350,=,1,0,=,,SD90,mg/kg/day,,120.0,CHEMBL612653,Plasmodium berghei,Plasmodium berghei,5821.0,,,SD90,mg/kg/day,UO_0000311,,120.0
102207,,,14682213,[],CHEMBL3285707,Ratio of quinine hydrochloride SD90 to compound SD90 for trophozoite-induced Plasmodium berghei infected in mouse assessed as daily dose required to suppression of 90% parasite infection administered with diet for 6 days,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2105350,=,1,0,=,,Ratio,,,0.6,CHEMBL612653,Plasmodium berghei,Plasmodium berghei,5821.0,,,Ratio,,,,0.6
102208,,Not Active,14683848,[],CHEMBL3285746,Antibacterial activity against sensitive Streptococcus faecium ATCC 8043 assessed as reduction in growth in presence of 0.002 ug/ml folic acid,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,INH,,UO_0000187,,
102209,,Not Active,14683879,[],CHEMBL3281543,Antibacterial activity against chlorguanide triazine-resistant Streptococcus faecium ATCC 8043 assessed as reduction in growth in presence of 0.002 ug/ml folic acid,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,INH,,UO_0000187,,
102210,,Not Active,14683905,[],CHEMBL3281544,Antibacterial activity against sensitive Lactobacillus casei ATCC 7469 assessed as reduction in growth in presence of 0.001 ug/ml folic acid,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,INH,,UO_0000187,,
102211,,Not Active,14683940,[],CHEMBL3281545,Antibacterial activity against chlorguanide triazine-resistant Lactobacillus casei ATCC 7469 assessed as reduction in growth in presence of 0.001 ug/ml folic acid,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,INH,,UO_0000187,,
102212,,Not Active,14683966,[],CHEMBL3281546,Antibacterial activity against sensitive Pediococcus cerevisiae ATCC 808 assessed as reduction in growth in presence of 0.001 ug/ml folinic acid,F,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
102213,,Not Active,14683997,[],CHEMBL3281547,Antibacterial activity against chlorguanide triazine-resistant Pediococcus cerevisiae ATCC 808 assessed as reduction in growth in presence of 0.001 ug/ml folinic acid,F,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
102214,,Active,14684022,[],CHEMBL3281548,Antibacterial activity against sensitive Escherichia coli ATCC 10536 assessed as reduction in growth in presence of p-aminobenzoic acid,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2104920,,1,0,,,Inhibition,%,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,,UO_0000187,,
102215,,,14684050,[],CHEMBL3281549,Antimalarial activity against Plasmodium berghei infected in sc dosed mouse assessed as active dose required to increase of 100% in mean survival time,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2104920,>,1,0,>,,MED,mg kg-1,,640.0,CHEMBL612653,Plasmodium berghei,Plasmodium berghei,5821.0,,,MED,mg kg-1,UO_0000308,,640.0
102216,,,14684088,[],CHEMBL3281550,Antimalarial activity against Plasmodium berghei infected in sc dosed mouse assessed as dose required to survivors for period of 60 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2104920,>,1,0,>,,MCD,mg kg-1,,640.0,CHEMBL612653,Plasmodium berghei,Plasmodium berghei,5821.0,,,MCD,mg kg-1,UO_0000308,,640.0
102217,,,14686995,[],CHEMBL3284086,Antibacterial activity against Streptococcus faecalis MGH-2 by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
102218,,,14687027,[],CHEMBL3284087,Antibacterial activity against Staphylococcus aureus UC-96 by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102219,,,14687059,[],CHEMBL3284088,Antibacterial activity against drug-resistant Staphylococcus aureus S18713 by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
102220,,,14687091,[],CHEMBL3284089,Antibacterial activity against Pseudomonas aeruginosa 28 by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,25.0
102221,,,14691288,[],CHEMBL3284090,Antibacterial activity against Escherichia coli Vogel by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
102222,,,14691320,[],CHEMBL3284091,Antibacterial activity against Shigella sonnei C-10 by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.25
102223,,,14691352,[],CHEMBL3284092,Antibacterial activity against Mycobacterium tuberculosis H37Ra by gradient plate test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272271,J Med Chem,1978.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105350,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,25.0
102224,,,14692962,[],CHEMBL3282587,Antibacterial activity against sensitive Streptococcus faecium ATCC 8043 assessed as reduction in growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.1,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,IC50,uM,UO_0000065,,0.08
102225,,,14693002,[],CHEMBL3282588,Antibacterial activity against chlorguanide triazine-resistant Streptococcus faecium ATCC 8043 assessed as reduction in growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272032,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.92,0,http://www.openphacts.org/units/Nanomolar,2104920,=,1,1,=,,IC50,nM,,1200.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,IC50,uM,UO_0000065,,1.2
102226,,,14693736,[],CHEMBL3280527,Inhibition of Escherichia coli dihydrofolate reductase,B,,,BAO_0000181,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,Activity,10'-8M,,0.5,CHEMBL1809,Escherichia coli,Dihydrofolate reductase,562.0,,,Activity,10'-8M,,,0.5
102227,,,14693743,[],CHEMBL3280528,Inhibition of Staphylococcus aureus dihydrofolate reductase,B,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,log(1/I50),,,1.5,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,log(1/I50),,,,1.5
102228,,,14693745,[],CHEMBL3280529,Inhibition of Proteus vulgaris dihydrofolate reductase,B,,,BAO_0000181,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,Activity,10'-8M,,0.5,CHEMBL612545,,Unchecked,,,,Activity,10'-8M,,,0.5
102229,,,14693747,[],CHEMBL3280530,Inhibition of human liver dihydrofolate reductase,B,,,BAO_0000181,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,Activity,10'-8M,,30000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Activity,10'-8M,,,30000.0
102230,,,14693749,[],CHEMBL3280531,Inhibition of rat liver dihydrofolate reductase,B,,,BAO_0000181,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,Activity,10'-8M,,26000.0,CHEMBL2363,Rattus norvegicus,Dihydrofolate reductase,10116.0,,,Activity,10'-8M,,,26000.0
102231,,,14693818,[],CHEMBL3280527,Inhibition of Escherichia coli dihydrofolate reductase,B,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3272349,J Med Chem,1977.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2112769,=,1,0,=,,log(1/I50),,,8.3,CHEMBL1809,Escherichia coli,Dihydrofolate reductase,562.0,,,log(1/I50),,,,8.3
102232,,,14758734,[],CHEMBL3301370,"ASTRAZENECA: Intrinsic clearance measured in human liver microsomes following incubation at 37C. Experimental range <3 to >150 microL/min/mg. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.",A,,,BAO_0002759,BAO_0000251,microsome format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3301361,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2127737,<,27,1,<,,CL,mL.min-1.g-1,,3.0,CHEMBL612558,,ADMET,,,,CLint,microL/min/mg,,,3.0
102233,,,14760778,[],CHEMBL3301365,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",A,,,BAO_0000179,BAO_0000366,cell-free format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3301361,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2127737,,27,1,,,PPB,%,,66.1,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,66.1
102234,,"""B1 Functional Group: 2,4-Pyrimidinediamine; Ionisation Formula: A0B1 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14765932,[],CHEMBL3301362,ASTRAZENECA: Most basic pKa value (pKa B1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Bases: >= 2.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3301361,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2127737,,27,0,,,pKa_B1,,,7.13,CHEMBL2362975,,No relevant target,,,,pKa_B1,,,,7.13
102235,,,14768154,[],CHEMBL3301363,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3301361,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2127737,,27,1,,,LogD7.4,,,0.63,CHEMBL2362975,,No relevant target,,,,LogD7.4,,,,0.63
102236,,,15049567,[],CHEMBL3369565,Binding affinity to DHFR (unknown origin) by NMR analysis,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3351755,J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2271580,=,1,1,=,,Ki,nM,,0.006,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Ki,pM,UO_0000065,,6.0
102237,,,15084164,[],CHEMBL3378887,Binding affinity to Bacillus anthracis DHFR assessed as tetrahydrofolate production,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352484,Bioorg Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.11,0,http://www.openphacts.org/units/Nanomolar,2273103,=,1,1,=,,Ki,nM,,77233.0,CHEMBL612545,,Unchecked,,,,Ki,nM,UO_0000065,,77233.0
102238,,,15084180,[],CHEMBL3378886,Antimicrobial activity against Bacillus anthracis assessed as growth inhibition measured as turbidity,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352484,Bioorg Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2273103,>,1,1,>,,MIC,ug.mL-1,,2048.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,2048.0
102239,,,15099236,[],CHEMBL3372741,Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352341,Eur J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.89,0,http://www.openphacts.org/units/Nanomolar,2257773,=,1,1,=,,IC50,nM,,13000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC50,uM,UO_0000065,,13.0
102240,,,15103753,[],CHEMBL3372742,Cytotoxicity against human foreskin fibroblasts after 5 days by colorimetric assay,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352341,Eur J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,2257773,>=,1,0,>=,,TD50,uM,,320.0,CHEMBL614071,Homo sapiens,HFF,9606.0,,,TD50,uM,UO_0000064,,320.0
102241,,Active,15103851,[],CHEMBL3372745,Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as inhibition of replication measured as decrease in the number of tachyzoites in vacuole at 10 uM after 24 hrs by fluorescence assay,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352341,Eur J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2257773,,1,0,,,Inhibition,%,,,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,INH,,UO_0000187,,
102242,,,15103924,[],CHEMBL3372747,"Therapeutic index, ratio of TD50 for human foreskin fibroblasts to IC50 for Toxoplasma gondii infected in human foreskin fibroblasts",A,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352341,Eur J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2257773,=,1,0,=,,TI,,,43.0,CHEMBL612558,,ADMET,,,,TI,,,,43.0
102243,,,15103997,[],CHEMBL3372741,Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay,F,,,BAO_0002144,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3352341,Eur J Med Chem,2014.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2257773,=,1,1,=,,IC90,nM,,73000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC90,uM,UO_0000065,,73.0
102244,,Not Determined,15198214,[],CHEMBL3412011,Solubility of the compound in phosphate buffered saline at pH 7.4 by UV spectrophotometry,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3407348,Eur J Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2289264,,1,0,,,solubility,,,,CHEMBL2362975,,No relevant target,,,,solubility,,,,
102245,,,15198222,[],CHEMBL3412010,Antiparasitic activity against promastigote form of Leishmania mexicana MHOM/BZ/61/M379 after 24 hrs by haemocytometer,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3407348,Eur J Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2289264,>,1,1,>,,IC50,nM,,100000.0,CHEMBL612880,Leishmania mexicana,Leishmania mexicana,5665.0,,,IC50,uM,UO_0000065,,100.0
102246,,,15198230,[],CHEMBL3412009,Antiparasitic activity against promastigote form of Leishmania mexicana MHOM/BZ/61/M379 at 100 uM after 24 hrs by haemocytometer,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3407348,Eur J Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2289264,=,1,1,=,,Inhibition,%,,30.0,CHEMBL612880,Leishmania mexicana,Leishmania mexicana,5665.0,,,INH,%,UO_0000187,,30.0
102247,,,15198241,[],CHEMBL3412014,Inhibition of Leishmania mexicana MHOM/BZ/61/M379 DHFR assessed as survival at 100 uM after 1 hr,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3407348,Eur J Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2289264,=,1,1,=,,Inhibition,%,,70.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,70.0
102248,,,15198242,[],CHEMBL3412015,Inhibition of Leishmania mexicana MHOM/BZ/61/M379 DHFR assessed as parasite survival at 100 uM after 1 hr in presence of 100 uM folic acid,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3407348,Eur J Med Chem,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2289264,=,1,1,=,,Inhibition,%,,100.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,100.0
102249,,,15446753,[],CHEMBL3529279,Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Ratio,,,68.0,CHEMBL612558,,ADMET,,,,Ratio,,,,68.0
102250,,,15446813,[],CHEMBL3529278,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Ratio,,,0.4,CHEMBL612558,,ADMET,,,,Ratio,,,,0.4
102251,,,15446873,[],CHEMBL3529277,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Papp,ucm/s,,11.6,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,11.6
102252,,,15446933,[],CHEMBL3529276,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Papp,ucm/s,,26.8,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,26.8
102253,,,15447007,[],CHEMBL3529274,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Ratio,,,0.7,CHEMBL612558,,ADMET,,,,Ratio,,,,0.7
102254,,,15450996,[],CHEMBL3541093,Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method,A,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526101,Drug Metab Dispos,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2470988,>,1,1,>,,IC50,nM,,50000.0,CHEMBL3491,Homo sapiens,Cytochrome P450 2J2,9606.0,,,IC50,uM,UO_0000065,,50.0
102255,,,15457382,[],CHEMBL3529273,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Papp,ucm/s,,11.2,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,11.2
102256,,,15458905,[],CHEMBL3529272,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Papp,ucm/s,,15.9,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,15.9
102257,,,15458970,[],CHEMBL3527758,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,2469146,=,1,0,=,,Fabs,%,,97.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fabs,%,UO_0000187,,97.0
102258,,,15464078,[],CHEMBL3529281,Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Ratio,,,38.0,CHEMBL612558,,ADMET,,,,Ratio,,,,38.0
102259,,,15464138,[],CHEMBL3529280,Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2469146,=,1,0,=,,Ratio,,,-4.0,CHEMBL612558,,ADMET,,,,Ratio,,,,-4.0
102260,,inactive,15472032,[],CHEMBL3561973,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2477504,,7,1,,,AC50,nM,,8920.0,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,8.92
102261,,inactive,15479660,[],CHEMBL3562085,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,2477504,,7,0,,,Ac50,uM,,8.913,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,8.9125093813
102262,,inactive,15480662,[],CHEMBL3562135,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2477504,,7,1,,,AC50,nM,,7943.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,7.9433
102263,,inactive,15483815,[],CHEMBL3562119,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2477504,,7,1,,,AC50,nM,,1412.5,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,1.4125
102264,,inactive,15505883,[],CHEMBL3562133,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2477504,,7,1,,,AC50,nM,,3548.1,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,3.5481
102265,,inactive,15509198,[],CHEMBL3562112,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,2477504,,7,0,,,Ac50,uM,,7.943,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,7.9432823472
102266,,inactive,15519739,[],CHEMBL3562088,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,2477504,,7,0,,,Ac50,uM,,3.548,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,3.5481338923
102267,,inactive,15578813,[],CHEMBL3561990,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL1201862,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,2477504,,7,0,,,Ac50,uM,,1.413,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,1.412537545
102268,,,16441126,[],CHEMBL3755615,Antimycobacterium activity against Mycobacterium tuberculosis H37Rv after 48 hrs by Resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3751663,ACS Med Chem Lett,2015.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2744825,=,1,1,=,,MIC,nM,,28930.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,28.93
102269,,Not Active,16537346,[],CHEMBL3789578,Cytotoxicity against human CCRF-CEM cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL382,Homo sapiens,CCRF-CEM,9606.0,,,TGI,,,,
102270,,Not Active,16537347,[],CHEMBL3789579,Cytotoxicity against human HL-60(TB) cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102271,,Not Active,16537348,[],CHEMBL3789580,Cytotoxicity against human K562 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL385,Homo sapiens,K562,9606.0,,,TGI,,,,
102272,,Not Active,16537349,[],CHEMBL3789581,Cytotoxicity against human MOLT4 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102273,,Not Active,16537350,[],CHEMBL3789582,Cytotoxicity against human RPMI8226 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102274,,Not Active,16537351,[],CHEMBL3789583,Cytotoxicity against human SR cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614300,Homo sapiens,SR,9606.0,,,TGI,,,,
102275,,Not Active,16537352,[],CHEMBL3789584,Cytotoxicity against human A549 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL392,Homo sapiens,A549,9606.0,,,TGI,,,,
102276,,Not Active,16537353,[],CHEMBL3789585,Cytotoxicity against human EKVX cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614487,Homo sapiens,EKVX,9606.0,,,TGI,,,,
102277,,Not Active,16537354,[],CHEMBL3789586,Cytotoxicity against human HOP62 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102278,,Not Active,16537355,[],CHEMBL3789587,Cytotoxicity against human HOP92 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102279,,Not Active,16537356,[],CHEMBL3789588,Cytotoxicity against human NCI-H226 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614740,Homo sapiens,NCI-H226,9606.0,,,TGI,,,,
102280,,Not Active,16537357,[],CHEMBL3789589,Cytotoxicity against human NCI-H23 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614997,Homo sapiens,NCI-H23,9606.0,,,TGI,,,,
102281,,Not Active,16537358,[],CHEMBL3789815,Cytotoxicity against human NCI-H322M cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614803,Homo sapiens,NCI-H322M,9606.0,,,TGI,,,,
102282,,Not Active,16537359,[],CHEMBL3789816,Cytotoxicity against human NCI-H460 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL396,Homo sapiens,NCI-H460,9606.0,,,TGI,,,,
102283,,Not Active,16537360,[],CHEMBL3789817,Cytotoxicity against human NCI-H522 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614387,Homo sapiens,NCI-H522,9606.0,,,TGI,,,,
102284,,Not Active,16537361,[],CHEMBL3789818,Cytotoxicity against human COLO205 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102285,,Not Active,16537362,[],CHEMBL3789819,Cytotoxicity against human HCC2998 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102286,,Not Active,16537363,[],CHEMBL3789820,Cytotoxicity against human HCT116 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102287,,Not Active,16537364,[],CHEMBL3789821,Cytotoxicity against human HCT15 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102288,,Not Active,16537365,[],CHEMBL3789822,Cytotoxicity against human HT-29 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL384,Homo sapiens,HT-29,9606.0,,,TGI,,,,
102289,,Not Active,16537366,[],CHEMBL3789823,Cytotoxicity against human KM12 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614709,Homo sapiens,KM12,9606.0,,,TGI,,,,
102290,,Not Active,16537367,[],CHEMBL3789824,Cytotoxicity against human SW620 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102291,,Not Active,16537368,[],CHEMBL3789825,Cytotoxicity against human SF268 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102292,,Not Active,16537369,[],CHEMBL3789826,Cytotoxicity against human SF295 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102293,,Not Active,16537370,[],CHEMBL3789827,Cytotoxicity against human SF539 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102294,,Not Active,16537371,[],CHEMBL3789828,Cytotoxicity against human SNB19 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102295,,Not Active,16537372,[],CHEMBL3789829,Cytotoxicity against human SNB75 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102296,,Not Active,16537373,[],CHEMBL3789830,Cytotoxicity against human U251 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL615022,Homo sapiens,U-251,9606.0,,,TGI,,,,
102297,,Not Active,16537374,[],CHEMBL3789831,Cytotoxicity against human LOXIMVI cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102298,,Not Active,16537375,[],CHEMBL3789832,Cytotoxicity against human MALME-3M cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614021,Homo sapiens,Malme-3M,9606.0,,,TGI,,,,
102299,,Not Active,16537376,[],CHEMBL3789833,Cytotoxicity against human M14 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614317,Homo sapiens,M14,9606.0,,,TGI,,,,
102300,,Not Active,16537377,[],CHEMBL3789834,Cytotoxicity against human MDA-MB-435 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614697,Homo sapiens,MDA-MB-435,9606.0,,,TGI,,,,
102301,,Not Active,16537378,[],CHEMBL3789835,Cytotoxicity against human SK-MEL-2 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614917,Homo sapiens,SK-MEL-2,9606.0,,,TGI,,,,
102302,,Not Active,16537379,[],CHEMBL3789836,Cytotoxicity against human SK-MEL-28 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614919,Homo sapiens,SK-MEL-28,9606.0,,,TGI,,,,
102303,,Not Active,16537380,[],CHEMBL3789837,Cytotoxicity against human SK-MEL-5 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614922,Homo sapiens,SK-MEL-5,9606.0,,,TGI,,,,
102304,,Not Active,16537381,[],CHEMBL3789838,Cytotoxicity against human UACC257 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102305,,Not Active,16537382,[],CHEMBL3789839,Cytotoxicity against human UACC62 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102306,,Not Active,16537383,[],CHEMBL3789840,Cytotoxicity against human IGROV1 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102307,,Not Active,16537384,[],CHEMBL3789841,Cytotoxicity against human OVCAR3 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102308,,Not Active,16537385,[],CHEMBL3789842,Cytotoxicity against human OVCAR4 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102309,,Not Active,16537386,[],CHEMBL3791890,Cytotoxicity against human OVCAR5 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102310,,Not Active,16537387,[],CHEMBL3791891,Cytotoxicity against human OVCAR8 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102311,,Not Active,16537388,[],CHEMBL3791892,Cytotoxicity against human NCI-ADR-RES cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102312,,Not Active,16537389,[],CHEMBL3791893,Cytotoxicity against human SKOV3 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102313,,Not Active,16537390,[],CHEMBL3791894,Cytotoxicity against human 786-0 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL613102,Homo sapiens,786-0,9606.0,,,TGI,,,,
102314,,Not Active,16537391,[],CHEMBL3791895,Cytotoxicity against human A498 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614516,Homo sapiens,A498,9606.0,,,TGI,,,,
102315,,Not Active,16537392,[],CHEMBL3791896,Cytotoxicity against human ACHN cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614519,Homo sapiens,ACHN,9606.0,,,TGI,,,,
102316,,Not Active,16537393,[],CHEMBL3791897,Cytotoxicity against human Caki1 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102317,,Not Active,16537394,[],CHEMBL3791898,Cytotoxicity against human RXF393 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102318,,Not Active,16537395,[],CHEMBL3791899,Cytotoxicity against human SN12C cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614054,Homo sapiens,SN12C,9606.0,,,TGI,,,,
102319,,Not Active,16537396,[],CHEMBL3791900,Cytotoxicity against human TK10 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102320,,Not Active,16537397,[],CHEMBL3791901,Cytotoxicity against human UO31 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102321,,Not Active,16537398,[],CHEMBL3791902,Cytotoxicity against human PC3 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102322,,Not Active,16537399,[],CHEMBL3791903,Cytotoxicity against human DU145 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102323,,Not Active,16537400,[],CHEMBL3791904,Cytotoxicity against human MCF7 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL387,Homo sapiens,MCF7,9606.0,,,TGI,,,,
102324,,Not Active,16537401,[],CHEMBL3791905,Cytotoxicity against human MDA-MB-231 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL400,Homo sapiens,MDA-MB-231,9606.0,,,TGI,,,,
102325,,Not Active,16537402,[],CHEMBL3791906,Cytotoxicity against human Hs 578T cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102326,,Not Active,16537403,[],CHEMBL3791907,Cytotoxicity against human BT549 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,TGI,,,,
102327,,Not Active,16537404,[],CHEMBL3791908,Cytotoxicity against human T47D cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614361,Homo sapiens,T47D,9606.0,,,TGI,,,,
102328,,Not Active,16537405,[],CHEMBL3791909,Cytotoxicity against human MDA-MB-468 cells assessed as tumor growth inhibition at 10'-5 M after 48 hrs by sulforhodamine B assay,F,,,BAO_0000194,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3785084,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2768838,,1,0,,,TGI,,,,CHEMBL614335,Homo sapiens,MDA-MB-468,9606.0,,,TGI,,,,
102329,,Not Determined,16650061,[],CHEMBL3830117,Inhibition of fluorescein-labeled probe binding to Bacillus anthracis N-terminal His-tagged DHPS incubated for 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826895,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2788062,,1,0,,,IC50,,,,CHEMBL1075045,Bacillus anthracis,Dihydropteroate synthase,1392.0,,,IC50,,,,
102330,,Not Determined,16650072,[],CHEMBL3830118,Inhibition of fluorescein-labeled probe binding to Bacillus anthracis N-terminal His-tagged DHPS incubated for 1 hr in presence of sodium pyrophosphate by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826895,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2788062,,1,0,,,IC50,,,,CHEMBL1075045,Bacillus anthracis,Dihydropteroate synthase,1392.0,,,IC50,,,,
102331,,,16650091,[],CHEMBL3830119,Antibacterial activity against Escherichia coli K-12 in M9 minimal media by turbidometric method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826895,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2788062,=,1,1,=,,MIC,nM,,1700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.7
102332,,,16650110,[],CHEMBL3830120,Antibacterial activity against Escherichia coli K-12 in M9 minimal media in presence of folate precursor PABA by turbidometric method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826895,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2788062,=,1,1,=,,MIC,nM,,1400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.4
102333,,,16650129,[],CHEMBL3830121,Antibacterial activity against Escherichia coli K-12 in M9 minimal media in presence of methionine by turbidometric method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826895,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2788062,=,1,1,=,,MIC,nM,,700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.7
102334,,,16653414,[],CHEMBL3829093,Inhibition of recombinant Staphylococcus aureus DHFR expressed in Escherichia coli BL21(DE3) cells assessed as reduction in NADPH oxidation using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition,B,,,BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,"{'bei': '29.16', 'le': '0.55', 'lle': '7.20', 'sei': '8.02'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.46,0,http://www.openphacts.org/units/Nanomolar,2788289,=,1,1,=,,Ki,nM,,3.43,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,3.43
102335,,,16653423,[],CHEMBL3829094,Inhibition of recombinant Escherichia coli DHFR expressed in Escherichia coli BL21(DE3) cells assessed as reduction in NADPH oxidation using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition,B,,,BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,"{'bei': '33.27', 'le': '0.63', 'lle': '8.40', 'sei': '9.15'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,9.66,0,http://www.openphacts.org/units/Nanomolar,2788289,=,1,1,=,,Ki,nM,,0.22,CHEMBL1809,Escherichia coli,Dihydrofolate reductase,562.0,,,Ki,nM,UO_0000065,,0.22
102336,,,16653432,[],CHEMBL3829095,Inhibition of recombinant human DHFR assessed as reduction in NADPH oxidation using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,"{'bei': '14.95', 'le': '0.28', 'lle': '3.08', 'sei': '4.11'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.34,0,http://www.openphacts.org/units/Nanomolar,2788289,=,1,1,=,,Ki,nM,,45783.5,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Ki,nM,UO_0000065,,45783.5
102337,,,16653441,[],CHEMBL3829096,Antibacterial activity against Staphylococcus aureus ATCC 43300 incubated for 18 hrs by presto blue reagent based micro dilution broth assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2788289,=,1,1,=,,MIC,ug.mL-1,,0.3125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3125
102338,,,16653451,[],CHEMBL3829097,Antibacterial activity against Escherichia coli ATCC 25922 by alamar blue reagent based micro dilution broth assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2788289,=,1,1,=,,MIC,ug.mL-1,,0.3125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3125
102339,,,16653461,[],CHEMBL3829098,Antibacterial activity against Escherichia coli NR698 harboring imp gene deletion mutant by alamar blue reagent based micro dilution broth assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2788289,=,1,1,=,,MIC,ug.mL-1,,0.0098,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0098
102340,,,16653550,[],CHEMBL3829228,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2788289,=,1,1,=,,MIC,ug.mL-1,,0.3125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3125
102341,,,16653551,[],CHEMBL3829229,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3826924,ACS Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2788289,=,1,1,=,,MIC,ug.mL-1,,0.3125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3125
102342,,,16800713,[],CHEMBL3868562,Antibacterial activity against Escherichia coli by agar well diffusion method,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3867489,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2808832,=,1,1,=,,MIC,nM,,55100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,55.1
102343,,,16800728,[],CHEMBL3868561,Antibacterial activity against Staphylococcus aureus by agar well diffusion method,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3867489,Bioorg Med Chem Lett,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2808832,=,1,1,=,,MIC,nM,,22700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.7
102344,,Not Active,17951909,[],CHEMBL3992916,Agonist activity at mouse TAAR1 expressed in HEK293 cells assessed as cAMP accumulation at 10 uM after 20 mins by BRET assay relative to beta-PEA,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3992498,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2974411,,1,0,,,Activity,,,,CHEMBL4908,Mus musculus,Trace amine-associated receptor 1,10090.0,,,Activity,,,,
102345,,Not Active,17951947,[],CHEMBL3992918,Agonist activity at human TAAR1 expressed in HEK293 cells assessed as cAMP accumulation at 10 uM after 20 mins by BRET assay relative to beta-PEA,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3992498,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2974411,,1,0,,,Activity,,,,CHEMBL5857,Homo sapiens,Trace amine-associated receptor 1,9606.0,,,Activity,,,,
102346,,,17951985,[],CHEMBL3992920,Agonist activity at mouse TAAR5 expressed in HEK293 cells assessed as cAMP accumulation after 20 mins by BRET assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL3992498,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2974411,>,1,1,>,,EC50,nM,,10000.0,CHEMBL3784908,Mus musculus,Trace amine-associated receptor 5,10090.0,,,EC50,uM,UO_0000065,,10.0
102347,,,18027610,[],CHEMBL4006949,Antimalarial activity against Plasmodium falciparum,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4004861,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987010,=,1,1,=,,IC50,ug.mL-1,,0.38,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,0.38
102348,,,18027659,[],CHEMBL4006954,Inhibition of bovine liver DHFR using FH2 as substrate preincubated for 2 mins followed by substrate addition in presence of NADPH,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4004861,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,2987010,=,1,1,=,,IC50,ug.mL-1,,0.042,CHEMBL1075051,Bos taurus,Dihydrofolate reductase,9913.0,,,IC50,ug ml-1,UO_0000274,,0.042
102349,,,18029937,[],CHEMBL4007201,Inhibition of human DHFR using dihydrofolate as substrate by spectrophotometric method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4004880,Bioorg Med Chem Lett,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/Nanomolar,2987427,=,1,1,=,,IC50,nM,,680000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,uM,UO_0000065,,680.0
102350,,,18029949,[],CHEMBL4007206,Inhibition of Escherichia coli DHFR using dihydrofolate as substrate by spectrophotometric method,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4004880,Bioorg Med Chem Lett,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.7,0,http://www.openphacts.org/units/Nanomolar,2987427,=,1,1,=,,IC50,nM,,20.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.02
102351,,,18040299,[],CHEMBL4009597,Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4007438,J Med Chem,2017.0,"{'bei': '14.79', 'le': '0.28', 'lle': '3.04', 'sei': '4.07'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.29,0,http://www.openphacts.org/units/Nanomolar,2989424,=,1,1,=,,IC50,nM,,50680.0,CHEMBL5685,Homo sapiens,Solute carrier family 22 member 1,9606.0,,,IC50,uM,UO_0000065,,50.68
102352,,,18040321,[],CHEMBL4009602,Ratio of Kii for human OCT1-ASP+-inhibitor complex to Kis for human OCT1-inhibitor complex by Lineweaver-Burk plot analysis,B,,,BAO_0000193,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4007438,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,2989424,=,1,0,=,,Ratio,,,1.26,CHEMBL5685,Homo sapiens,Solute carrier family 22 member 1,9606.0,,,Ratio,,,95.62,1.26
102353,,,18051944,[],CHEMBL4011663,Inhibition of human BSEP expressed in fall armyworm sf9 cell plasma membrane vesicles assessed as reduction in vesicle-associated [3H]-taurocholate transport preincubated for 10 mins prior to ATP addition measured after 15 mins in presence of [3H]-taurocholate by topcount based membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4011581,Toxicol Sci,2010.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2991842,>,1,1,>,,IC50,nM,,135000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,135.0
102354,,,18071088,[],CHEMBL4015290,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
102355,,,18071199,[],CHEMBL4015291,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
102356,,,18071213,[],CHEMBL4015292,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
102357,,,18071227,[],CHEMBL4015293,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P259-96918 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
102358,,,18071241,[],CHEMBL4015294,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P262-101856 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,>,1,1,>,,MIC,ug.mL-1,,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1024.0
102359,,,18071255,[],CHEMBL4015295,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P264-104354 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
102360,,,18071269,[],CHEMBL4015296,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 91433 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
102361,,,18071283,[],CHEMBL4015297,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 101243 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995416,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1024.0
102362,,,18081191,[],CHEMBL4017550,Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method,A,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4017441,Drug Metab Dispos,2012.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,2997649,=,1,1,=,,IC50,nM,,833100.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,833.1
102363,,,18129550,[],CHEMBL4028921,Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3006888,>,1,1,>,,IC50,nM,,133000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,133.0
102364,,,18130120,[],CHEMBL4028922,Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3006888,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,IC50,uM,UO_0000065,,133.0
102365,,,18130720,[],CHEMBL4028923,Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3006888,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,IC50,uM,UO_0000065,,133.0
102366,,,18131320,[],CHEMBL4028924,Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3006888,>,1,1,>,,IC50,nM,,133000.0,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,IC50,uM,UO_0000065,,133.0
102367,,,18131950,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3006948,=,1,0,=,,DILI_severity_class,,,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,4.0
102368,,Less-Dili-Concern,18132550,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3006948,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
102369,,,18236828,[],CHEMBL4051382,Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs,F,,,BAO_0002146,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4049433,J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3026391,=,1,1,=,,MIC,ug.mL-1,,0.35,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.35
102370,,,18251253,[],CHEMBL4054630,Selectivity ratio of Ki for Pneumocystis carinii DHFR to Ki for human DHFR,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3028817,=,1,0,=,,Ratio Ki,,,6.0,CHEMBL612545,,Unchecked,,,,Ratio Ki,,,,6.0
102371,,,18251254,[],CHEMBL4054631,Inhibition of Pneumocystis carinii DHFR,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,=,1,1,=,,Ki,nM,,280000.0,CHEMBL1926,Pneumocystis carinii,Dihydrofolate reductase,4754.0,,,Ki,uM,UO_0000065,,280.0
102372,,,18251255,[],CHEMBL4054634,Inhibition of human DHFR,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,"{'bei': '14.88', 'le': '0.28', 'lle': '3.06', 'sei': '4.09'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.32,0,http://www.openphacts.org/units/Nanomolar,3028817,=,1,1,=,,Ki,nM,,48000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Ki,uM,UO_0000065,,48.0
102373,,,18251288,[],CHEMBL4054629,Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009(H1N1) infected in MDCK cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by formazan-based colorimetric assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,83000.0,CHEMBL612545,,Unchecked,,,,EC50,uM,UO_0000065,,83.0
102374,,,18251325,[],CHEMBL4054628,Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009(H1N1) infected in MDCK cells assessed as host cell viability measured after 3 to 6 days post infection by MTS assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,83000.0,CHEMBL612545,,Unchecked,,,,EC50,uM,UO_0000065,,83.0
102375,,,18251362,[],CHEMBL4054627,Antiviral activity against Influenza A virus A/Ned/378/05(H1N1) infected in MDCK cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by formazan-based colorimetric assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613740,Influenza A virus,Influenza A virus,11320.0,,,EC50,uM,UO_0000065,,100.0
102376,,,18251399,[],CHEMBL4054626,Antiviral activity against Influenza A virus A/Ned/378/05(H1N1) infected in MDCK cells assessed as host cell viability measured after 3 to 6 days post infection by MTS assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613740,Influenza A virus,Influenza A virus,11320.0,,,EC50,uM,UO_0000065,,100.0
102377,,,18251436,[],CHEMBL4054625,Antiviral activity against Influenza B virus B/Ned/537/05 infected in MDCK cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by formazan-based colorimetric assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520.0,,,EC50,uM,UO_0000065,,100.0
102378,,,18251473,[],CHEMBL4054624,Antiviral activity against Influenza B virus B/Ned/537/05 infected in MDCK cells assessed as host cell viability measured after 3 to 6 days post infection by MTS assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL612545,,Unchecked,,,,EC50,uM,UO_0000065,,100.0
102379,,,18251510,[],CHEMBL4054623,Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 5 to 6 days by MTS assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,CC50,uM,UO_0000065,,100.0
102380,,,18251547,[],CHEMBL4054622,Cytotoxicity against dog MDCK cells assessed as alterations in normal cell morphology measured after 5 to 6 days post infection by microscopic analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,MCC,nM,,100000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,MCC,uM,UO_0000065,,100.0
102381,,,18251584,[],CHEMBL4054620,Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613739,Vesicular stomatitis virus,Vesicular stomatitis virus,11276.0,,,EC50,uM,UO_0000065,,100.0
102382,,,18251618,[],CHEMBL4054619,Antiviral activity against coxsackie B4 virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL612320,Coxsackievirus B4,Coxsackievirus B4,12073.0,,,EC50,uM,UO_0000065,,100.0
102383,,,18251652,[],CHEMBL4054618,Cytotoxicity against human HeLa cells assessed as alterations in cell morphology measured after 5 to 6 days post infection by microscopic analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,MCC,nM,,100000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,MCC,uM,UO_0000065,,100.0
102384,,,18251686,[],CHEMBL4054621,Antiviral activity against para influenza 3 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613126,Human respirovirus 3,Human respirovirus 3,11216.0,,,EC50,uM,UO_0000065,,100.0
102385,,,18251721,[],CHEMBL4054617,Antiviral activity against Reovirus 1 infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL612927,Mammalian orthoreovirus 1,Mammalian orthoreovirus 1,538120.0,,,EC50,uM,UO_0000065,,100.0
102386,,,18251756,[],CHEMBL4054616,Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034.0,,,EC50,uM,UO_0000065,,100.0
102387,,,18251791,[],CHEMBL4054615,Antiviral activity against Coxsackie B4 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL612320,Coxsackievirus B4,Coxsackievirus B4,12073.0,,,EC50,uM,UO_0000065,,100.0
102388,,,18251826,[],CHEMBL4054614,Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613741,Punta Toro virus,Punta Toro virus,11587.0,,,EC50,uM,UO_0000065,,100.0
102389,,,18251861,[],CHEMBL4054613,Antiviral activity against Yellow fever virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL613731,Yellow fever virus,Yellow fever virus,11089.0,,,EC50,uM,UO_0000065,,100.0
102390,,,18251897,[],CHEMBL4054633,Cytotoxicity against African green monkey Vero cells assessed as alterations in cell morphology measured after 5 to 6 days post infection by microscopic analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,MCC,nM,,100000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,MCC,uM,UO_0000065,,100.0
102391,,,18251945,[],CHEMBL4054609,Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4052640,Eur J Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3028817,>,1,1,>,,EC50,nM,,100000.0,CHEMBL612679,Respiratory syncytial virus,Respiratory syncytial virus,12814.0,,,EC50,uM,UO_0000065,,100.0
102392,,,18417879,[],CHEMBL4153465,Antileishmanial activity against Leishmania major assessed as parasite survival at 100 uM after 48 hrs relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4152215,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3056787,=,1,0,=,,Activity,%,,69.0,CHEMBL612879,Leishmania major,Leishmania major,5664.0,,,Activity,%,UO_0000187,,69.0
102393,,,18417880,[],CHEMBL4153470,Antileishmanial activity against Leishmania major assessed as parasite survival at 100 uM after 48 hrs in presence of 100 uM folic acid relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4152215,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3056787,=,1,0,=,,Activity,%,,99.0,CHEMBL612879,Leishmania major,Leishmania major,5664.0,,,Activity,%,UO_0000187,,99.0
102394,,,18466841,[],CHEMBL4181904,Antimalarial activity against Plasmodium falciparum in infected in human RBC,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4177685,Bioorg Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3064974,=,1,1,=,,IC50,ug.mL-1,,0.38,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,0.38
102395,,,18466863,[],CHEMBL4181905,Inhibition of bovine liver DHFR using FH2 as substrate preincubated for 2 mins followed by substrate addition,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4177685,Bioorg Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3064974,=,1,1,=,,IC50,ug.mL-1,,0.042,CHEMBL1075051,Bos taurus,Dihydrofolate reductase,9913.0,,,IC50,ug ml-1,UO_0000274,,0.042
102396,,Not Determined,18466874,[],CHEMBL4181908,Cytotoxicity against African green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4177685,Bioorg Med Chem,2017.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3064974,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
102397,,,18589117,[],CHEMBL4224045,Inhibition of Pneumocystis jirovecii recombinant DHFR expressed in Escherichia coli Rosetta Gami B (DE3) competent cells using DHFA as substrate and NADPH,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4219246,Bioorg Med Chem,2018.0,"{'bei': '24.24', 'le': '0.46', 'lle': '5.78', 'sei': '6.67'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.04,0,http://www.openphacts.org/units/Nanomolar,3087167,=,1,1,=,,IC50,nM,,92.0,CHEMBL2057,Pneumocystis jirovecii,Dihydrofolate reductase,42068.0,,,IC50,nM,UO_0000065,,92.0
102398,,,18589137,[],CHEMBL4224046,Inhibition of human recombinant DHFR expressed in Escherichia coli Rosetta Gami B (DE3) competent cells using DHFA as substrate and NADPH,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4219246,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.61,0,http://www.openphacts.org/units/Nanomolar,3087167,=,1,1,=,,IC50,nM,,24500.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,nM,UO_0000065,,24500.0
102399,,,18589157,[],CHEMBL4224047,Selectivity ratio of IC50 for human recombinant DHFR to IC50 for Pneumocystis jirovecii recombinant DHFR,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4219246,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3087167,=,1,0,=,,Ratio IC50,,,266.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,266.0
102400,,Not Determined,18700158,[],CHEMBL4254750,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 after overnight incubation by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4251638,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3105605,,1,0,,,MIC90,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,,,,
102401,,Not Determined,18700201,[],CHEMBL4254749,Antibacterial activity against Salmonella typhimurium ATCC 14028 after overnight incubation by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4251638,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3105605,,1,0,,,MIC90,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC90,,,,
102402,,,18700215,[],CHEMBL4254748,Antibacterial activity against Escherichia coli ATCC 25922 after overnight incubation by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4251638,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3105605,=,1,1,=,,MIC90,nM,,55100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,uM,UO_0000065,,55.1
102403,,Not Determined,18700241,[],CHEMBL4254747,Antibacterial activity against Bacillus subtilis ATCC 6633 after overnight incubation by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4251638,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3105605,,1,0,,,MIC90,,,,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC90,,,,
102404,,,18700267,[],CHEMBL4254746,Antibacterial activity against Staphylococcus aureus ATCC 6538 after overnight incubation by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4251638,Eur J Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3105605,=,1,1,=,,MIC90,nM,,22700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,uM,UO_0000065,,22.7
102405,,,18786420,[],CHEMBL4271751,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 at 5 ug after 18 to 20 hrs by CLSI disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3121903,=,1,1,=,,IZ,mm,,20.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,20.19
102406,,,18786425,[],CHEMBL4271750,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 at 5 ug after 18 to 20 hrs by CLSI disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3121903,=,1,1,=,,IZ,mm,,22.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.8
102407,,,18786430,[],CHEMBL4271752,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus COL at 5 ug after 18 to 20 hrs by CLSI disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3121903,=,1,1,=,,IZ,mm,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,6.0
102408,,,18786435,[],CHEMBL4271753,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 after 20 hrs by CLSI microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
102409,,,18786441,[],CHEMBL4271754,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 after 20 hrs by CLSI microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
102410,,,18786447,[],CHEMBL4271755,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus COL after 20 hrs by CLSI microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
102411,,,18786453,[],CHEMBL4271756,Bactericidal activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 preincubated for 20 hrs followed by agar plating and measured after 18 to 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,0,=,,MBC,ug ml-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.25
102412,,,18786458,[],CHEMBL4271757,Bactericidal activity against methicillin-resistant Staphylococcus aureus USA300 preincubated for 20 hrs followed by agar plating and measured after 18 to 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,0,=,,MBC,ug ml-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.5
102413,,,18786463,[],CHEMBL4271758,Bactericidal activity against hospital-associated methicillin-resistant Staphylococcus aureus COL preincubated for 20 hrs followed by agar plating and measured after 18 to 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,0,=,,MBC,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,10.0
102414,,,18786471,[],CHEMBL4271760,Potentiation of sulfamethoxazole-mediated antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 assessed as sulfamethoxazole MIC after 20 hrs by CLSI microdilution assay (Rvb = 100 microg/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
102415,,,18786479,[],CHEMBL4271765,Synergistic antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in presence of sulfamethoxazole after 20 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FIC,,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FIC,,,,0.06
102416,,,18786487,[],CHEMBL4271770,Synergistic antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 assessed as fractional inhibitory concentration index in presence of sulfamethoxazole after 18 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FICI,,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.12
102417,,,18786491,[],CHEMBL4271771,Potentiation of sulfamethoxazole-mediated antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as sulfamethoxazole MIC after 20 hrs by CLSI microdilution assay (Rvb = 100 microg/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
102418,,,18786499,[],CHEMBL4271776,Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 in presence of sulfamethoxazole after 20 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FIC,,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FIC,,,,0.06
102419,,,18786506,[],CHEMBL4271780,Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as fractional inhibitory concentration index in presence of sulfamethoxazole after 18 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FICI,,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.12
102420,,,18786510,[],CHEMBL4271781,Potentiation of sulfamethoxazole-mediated antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus COL assessed as sulfamethoxazole MIC after 20 hrs by CLSI microdilution assay (Rvb = 200 microg/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121903,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
102421,,,18786518,[],CHEMBL4271786,Synergistic antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus COL in presence of sulfamethoxazole after 20 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FIC,,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FIC,,,,0.06
102422,,,18786526,[],CHEMBL4271791,Synergistic antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus COL assessed as fractional inhibitory concentration index in presence of sulfamethoxazole after 18 hrs by broth microdilution-based checkerboard titration assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4270522,Bioorg Med Chem,2018.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3121903,=,1,0,=,,FICI,,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.12
102423,,,18828463,[],CHEMBL4303819,Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4303097,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3135005,=,52,0,=,,Inhibition index,,,0.0604,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition index,,,,0.06039823
102424,,,18829082,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4303101,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3135580,=,52,1,=,,Inhibition,%,,1.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,1.15
102425,,,18853226,[],CHEMBL4306900,Inhibition of DHFR-TS/PTR1 in Leishmania major promastigote form assessed as parasite survival at 100 uM measured after 48 hrs relative to control,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4304772,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3147001,=,1,0,=,,Survival,%,,69.0,CHEMBL612545,,Unchecked,,,,Survival,%,UO_0000187,,69.0
102426,,,18853239,[],CHEMBL4306903,Inhibition of DHFR-TS/PTR1 in Leishmania major promastigote form assessed as parasite survival at 100 uM measured after 48 hrs in presence of 100 uM folic acid relative to control,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4304772,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3147001,=,1,0,=,,Survival,%,,99.0,CHEMBL612545,,Unchecked,,,,Survival,%,UO_0000187,,99.0
102427,,Active,18853249,[],CHEMBL4306904,Reversible inhibition of DHFR-TS/PTR1 in Leishmania major promastigote form in presence of excess folic acid,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4304772,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3147001,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
102428,,,18931388,[],CHEMBL4325785,Protein binding in plasma (unknown origin),A,,,BAO_0000179,BAO_0000366,cell-free format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3158159,=,1,1,=,,PPB,%,,37.5,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,41.5,37.5
102429,,,18931424,[],CHEMBL4325787,Protein binding in immobilized human serum albumin by HPLC analysis,A,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3158159,=,1,1,=,,PPB,%,,37.3,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,PB,%,UO_0000187,,37.3
102430,,,18931448,[],CHEMBL4325788,Protein binding in human serum albumin after 4.5 hrs by LC-MS based rapid equilibrium dialysis method,A,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3158159,=,1,1,=,,PPB,%,,3.1,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,PB,%,UO_0000187,,3.1
102431,,,18931474,[],CHEMBL4325789,Binding affinity to human serum albumin assessed as change in dissociation constant pKa1 of compound in aqueous medium to presence of human serum albumin by UV-pH titration based spectrophotometric analysis,A,,,BAO_0002131,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3158159,=,1,0,=,,pKa,,,0.01,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,pKa,,,,0.01
102432,,Not Determined,18965970,[],CHEMBL4335879,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter 96 Non-radioactive Cell Proliferation Assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4334450,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3164297,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
102433,,,18965978,[],CHEMBL4335873,Inhibition of bovine liver DHFR using FH2 as substrate incubated for 2 mins followed by substrate addition,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4334450,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,3164297,=,1,1,=,,IC50,ug.mL-1,,0.042,CHEMBL1075051,Bos taurus,Dihydrofolate reductase,9913.0,,,IC50,ug ml-1,UO_0000274,,0.042
102434,,,18966010,[],CHEMBL4335874,Antimalarial activity against Plasmodium falciparum FCR3 infected in human erythrocytes by Giemsa staining analysis,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4334450,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164297,=,1,1,=,,IC50,ug.mL-1,,0.38,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,0.38
102435,,,18966036,[],CHEMBL4335874,Antimalarial activity against Plasmodium falciparum FCR3 infected in human erythrocytes by Giemsa staining analysis,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4334450,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.42,0,http://www.openphacts.org/units/Nanomolar,3164297,=,1,1,=,,IC50,nM,,380.19,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,pIC50,,UO_0000065,,6.42
102436,,,19001072,[],CHEMBL4343477,Antimicrobial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170455,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,125.0
102437,,,19001073,[],CHEMBL4343478,Antimicrobial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170455,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,500.0
102438,,,19001074,[],CHEMBL4343479,Antimicrobial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170455,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,250.0
102439,,,19192942,[],CHEMBL4390131,Inhibition of Pneumocystis jirovecii DHFR expressed in Escherichia coli Rosetta-gami B (DE3) assessed as reduction in consumption of NADPH using 18 uM DHFA as substrate,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.92,0,http://www.openphacts.org/units/Nanomolar,3203446,=,1,1,=,,IC50,nM,,120.0,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,120.0
102440,,,19192951,[],CHEMBL4390132,Inhibition of recombinant human DHFR assessed as reduction in consumption of NADPH using 18 uM DHFA as substrate,A,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.49,1,http://www.openphacts.org/units/Nanomolar,3203446,=,1,1,=,,IC50,nM,,32200.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,nM,UO_0000065,,32200.0
102441,,,19192964,[],CHEMBL4390135,Selectivity ratio of IC50 for inhibition of recombinant human DHFR using 18 uM DHFA as substrate to IC50 for inhibition of Pneumocystis jirovecii DHFR using 18 uM DHFA as substrate,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3203446,=,1,0,=,,Ratio IC50,,,268.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,268.0
102442,,,19192981,[],CHEMBL4390136,Inhibition of Pneumocystis jirovecii DHFR expressed in Escherichia coli Rosetta-gami B (DE3) assessed as reduction in consumption of NADPH using 9 uM DHFA as substrate,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.04,0,http://www.openphacts.org/units/Nanomolar,3203446,=,1,1,=,,IC50,nM,,92.0,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,92.0
102443,,,19192997,[],CHEMBL4390137,Inhibition of recombinant human DHFR assessed as reduction in consumption of NADPH using 9 uM DHFA as substrate,A,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.61,1,http://www.openphacts.org/units/Nanomolar,3203446,=,1,1,=,,IC50,nM,,24500.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,nM,UO_0000065,,24500.0
102444,,,19193013,[],CHEMBL4390138,Selectivity ratio of IC50 for inhibition of recombinant human DHFR using 9 uM DHFA as substrate to IC50 for inhibition of Pneumocystis jirovecii DHFR using 9 uM DHFA as substrate,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4387751,Bioorg Med Chem Lett,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3203446,=,1,0,=,,Ratio IC50,,,266.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,266.0
102445,,,19284415,[],CHEMBL4409705,Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 24 hrs by MTT assay,A,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4406869,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,3220334,=,1,0,=,,CC30,uM,,55.11,CHEMBL612267,Mus musculus,L929,10090.0,,,CC30,uM,UO_0000064,,55.11
102446,,,19284423,[],CHEMBL4409706,"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis",F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4406869,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.38,0,http://www.openphacts.org/units/Nanomolar,3220334,=,1,1,=,,IC50,nM,,41780.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC50,uM,UO_0000065,,41.78
102447,,,19284591,[],CHEMBL4409732,Selectivity ratio of CC30 for cytotoxicity against mouse L929 cells to IC50 for antiparasitic activity against Toxoplasma gondii RH infected in human Hs27 cells,T,,,BAO_0002136,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4406869,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3220334,=,1,0,=,,Selectivity ratio,,,1.32,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,1.32
102448,,,19284599,[],CHEMBL4409733,"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis",F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4406869,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.41,0,http://www.openphacts.org/units/Nanomolar,3220334,=,1,1,=,,IC50,nM,,39230.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC50,uM,UO_0000065,,39.23
102449,,,19284607,[],CHEMBL4409734,Selectivity ratio of CC30 for cytotoxicity against mouse L929 cells to IC50 for antiparasitic activity against Toxoplasma gondii Me49 infected in human Hs27 cells,T,,,BAO_0002136,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4406869,Eur J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3220334,=,1,0,=,,Selectivity ratio,,,1.4,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,1.4
102450,,,19314400,[],CHEMBL4416747,Antibacterial activity against Escherichia coli K-12 assessed as reduction in bacterial growth incubated for 16 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3225250,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
102451,,Non-Toxic,19314458,[],CHEMBL4416768,Cytotoxicity in human HS5 cells assessed as reduction in cell viability at 0.5 to 50 uM incubated up to 72 hrs relative to chloramphenicol,A,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3225250,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
102452,,Toxic,19314512,[],CHEMBL4416770,Cytotoxicity in human HEK293 cells assessed as reduction in cell viability at 0.5 uM incubated up to 72 hrs relative to chloramphenicol,A,,,BAO_0000375,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3225250,,1,0,,,Activity,,,,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,Activity,,,,
102453,,,19365486,[],CHEMBL4423793,Intrinsic clearance in human liver microsomes at 10 uM preincubated for 10 mins followed by NADPH addition and measured up to 60 mins by LC/MS/MS analysis,A,,,BAO_0002759,BAO_0000251,microsome format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4422638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3241137,<,1,1,<,,CL,mL.min-1.kg-1,,8.6,CHEMBL612558,,ADMET,,,,CLH,ml/min.kg,,,8.6
102454,,,19365527,[],CHEMBL4423791,Selectivity ratio of IC50 for human DHFR to IC50 for Toxoplasma gondii DHFR-TS,T,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4422638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3241137,=,1,0,=,,Ratio IC50,,,15.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,15.0
102455,,,19365558,[],CHEMBL4423790,Inhibition of human DHFR expressed in Escherichia coli BL21 competent cells using DHF as substrate preincubated for 15 mins followed by substrate and NADPH addition and measured after 60 mins by resazurin dye based diaphorase-coupled assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4422638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3241137,=,1,1,=,,IC50,nM,,503000.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,nM,UO_0000065,,503000.0
102456,,,19365589,[],CHEMBL4423789,Inhibition of Toxoplasma gondii DHFR-TS expressed in Escherichia coli BL21 competent cells using DHF as substrate preincubated for 15 mins followed by substrate and NADPH addition and measured after 60 mins by resazurin dye based diaphorase-coupled assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4422638,J Med Chem,2019.0,"{'bei': '15.43', 'le': '0.29', 'lle': '3.22', 'sei': '4.25'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.48,0,http://www.openphacts.org/units/Nanomolar,3241137,=,1,1,=,,IC50,nM,,33100.0,CHEMBL2425,Toxoplasma gondii,Dihydrofolate reductase,5811.0,,,IC50,nM,UO_0000065,,33100.0
102457,,,19365602,[],CHEMBL4423794,Apparent permeability from apical to basolateral side in MDCK-MDR1 cells at 2 uM after 15 mins by LC/MS/MS analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4422638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3241137,=,1,0,=,,Papp,10'-6 cm/s,,7.5,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,7.5
102458,,,19365612,[],CHEMBL4423795,Efflux ratio of apparent permeability in MDCK-MDR1 cells at 2 uM after 15 mins by LC/MS/MS analysis,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4422638,J Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3241137,=,1,0,=,,Ratio,,,3.5,CHEMBL612558,,ADMET,,,,Ratio,,,,3.5
102459,,,19471512,[],CHEMBL4478710,Inhibition of TMP/methicillin-resistant Staphylococcus aureus wild type DHFR assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '29.16', 'le': '0.55', 'lle': '7.20', 'sei': '8.02'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.46,1,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,3.43,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,3.43
102460,,,19471519,[],CHEMBL4478712,Inhibition of TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR H30N mutant expressed in Escherichia coli BL21 (DE3) cells assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,P0A017,H31N,BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '28.11', 'le': '0.53', 'lle': '6.90', 'sei': '7.74'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.16,0,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,6.89,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,6.89
102461,,,19471532,[],CHEMBL4478711,Inhibition of TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR F98Y mutant expressed in Escherichia coli BL21 (DE3) cells assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,P0A017,F99Y,BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '26.98', 'le': '0.51', 'lle': '6.57', 'sei': '7.42'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.83,0,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,14.68,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,14.68
102462,,,19471551,[],CHEMBL4478713,Inhibition of TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR H149R mutant expressed in Escherichia coli BL21 (DE3) cells assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,P0A017,H150R,BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '22.80', 'le': '0.43', 'lle': '5.36', 'sei': '6.27'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.62,0,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,240.8,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,240.8
102463,,,19471564,[],CHEMBL4478714,Inhibition of TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR H30N/F98Y double mutant expressed in Escherichia coli BL21 (DE3) cells assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,P0A017,"H31N,F99Y",BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '21.44', 'le': '0.40', 'lle': '4.97', 'sei': '5.90'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.22,0,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,595.1,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,595.1
102464,,,19471577,[],CHEMBL4478715,Inhibition of TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR F98Y/H149R double mutant expressed in Escherichia coli BL21 (DE3) cells assessed as oxidation of NADPH pre-incubated for 5 mins followed by dihydrofolate substrate addition,B,P0A017,"F99Y,H150R",BAO_0000192,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,"{'bei': '19.85', 'le': '0.37', 'lle': '4.50', 'sei': '5.46'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.76,0,http://www.openphacts.org/units/Nanomolar,3255927,=,1,1,=,,Ki,nM,,1729.0,CHEMBL1681620,Staphylococcus aureus,Dihydrofolate reductase,1280.0,,,Ki,nM,UO_0000065,,1729.0
102465,,,19471590,[],CHEMBL4478716,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,0.3125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3125
102466,,,19471603,[],CHEMBL4478717,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus harboring DHFR F98Y mutant after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
102467,,,19471616,[],CHEMBL4478718,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus harboring DHFR H30N mutant after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.5
102468,,,19471629,[],CHEMBL4478719,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus harboring DHFR H149R mutant after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.5
102469,,,19471642,[],CHEMBL4478720,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus harboring DHFR H30N/F98Y double mutant after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
102470,,,19471655,[],CHEMBL4478721,Antibacterial activity against TMP/methicillin-resistant Staphylococcus aureus harboring DHFR F98Y/H149R double mutant after 18 hrs by CLSI M100-S16 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255927,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
102471,,,19471669,[],CHEMBL4478723,Selectivity ratio of Ki for TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR H149R mutant expressed in Escherichia coli BL21 (DE3) cells to Ki for TMP/methicillin-resistant Staphylococcus aureus wild type DHFR,B,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3255927,=,1,0,=,,Ratio Ki,,,69.0,CHEMBL612545,,Unchecked,,,,Ratio Ki,,,,69.0
102472,,,19471670,[],CHEMBL4478724,Selectivity ratio of Ki for TMP/methicillin-resistant Staphylococcus aureus recombinant DHFR H30N/F98Y double mutant expressed in Escherichia coli BL21 (DE3) cells to Ki for TMP/methicillin-resistant Staphylococcus aureus wild type DHFR,B,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4477218,J Med Chem,2016.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3255927,=,1,0,=,,Ratio Ki,,,130.0,CHEMBL612545,,Unchecked,,,,Ratio Ki,,,,130.0
102473,,,19956448,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495564,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3342866,=,52,1,=,,Inhibition,%,,1.7,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,1.7
102474,,,19959982,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495564,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3346400,=,52,1,=,,Inhibition,%,,12.64,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,12.63560552
102475,,,20146165,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495565,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3360738,=,52,1,=,,Inhibition,%,,-0.03,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.03
102476,,,20151939,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495565,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3364272,=,52,1,=,,Inhibition,%,,-0.04,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.04
102477,,Median N= 2; Maxinhib 7.9 Pct,20163936,[],CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,>,40,1,>,,MIC,nM,,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,uM,UO_0000065,,10.0
102478,,Median N= 2; Maxinhib 4.5 Pct,20163937,[],CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,>,40,1,>,,MIC,nM,,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,uM,UO_0000065,,10.0
102479,,Median N= 2; Range 2.5 - 1.25  Um,20163938,[],CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,=,40,1,=,,MIC,nM,,1250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.25
102480,,Median N= 2,20163939,[],CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,=,40,1,=,,MIC,nM,,10000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,10.0
102481,,Median N= 2; Maxinhib 23.1 Pct,20163940,[],CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,>,40,1,>,,MIC,nM,,10000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,10.0
102482,,Median N= 2; Maxinhib 10.9 Pct,20163941,[],CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,>,40,1,>,,MIC,nM,,10000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,10.0
102483,,Median N= 2,20163942,[],CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,=,40,1,=,,MIC,nM,,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,5.0
102484,,Median N= 2; Maxinhib 14.6 Pct,20163943,[],CHEMBL4296191,"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)",F,,,BAO_0000187,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513141,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3370162,>,40,1,>,,CC50,nM,,10000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,CC50,uM,UO_0000065,,10.0
102485,,Median N= 2; Maxinhib 1.4 Pct,20239362,[],CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,>,40,1,>,,MIC,nM,,20000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,uM,UO_0000065,,20.0
102486,,Median N= 2; Maxinhib 9.3 Pct,20239363,[],CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,>,40,1,>,,MIC,nM,,20000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,uM,UO_0000065,,20.0
102487,,Median N= 2,20239364,[],CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,=,40,1,=,,MIC,nM,,2500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,2.5
102488,,Median N= 2; Range 10 - 5  Um,20239365,[],CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,=,40,1,=,,MIC,nM,,5000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,5.0
102489,,Median N= 2; Range >20 - 20  Um,20239366,[],CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,=,40,1,=,,MIC,nM,,20000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,20.0
102490,,Median N= 2; Maxinhib 24.8 Pct,20239367,[],CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,>,40,1,>,,MIC,nM,,20000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,20.0
102491,,Median N= 2,20239368,[],CHEMBL4296802,"Antibacterial activity against Pseudomonas aeruginosa PAO397 [PAO1 d(mexAB-oprM) d(mexCD-oprJ) d(mexEF-oprN) d(mexJKL) d(mexXY) d(opmH)] (CO-ADD:GN_211); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,=,40,1,=,,MIC,nM,,5000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,5.0
102492,,Median N= 2,20239369,[],CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,=,40,1,=,,MIC,nM,,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,5.0
102493,,Median N= 2; Maxinhib 9.1 Pct,20239370,[],CHEMBL4296784,"Haemolysis of human Red Blood Cells (CO-ADD:HA_150); HC10, by OD(450)",F,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Micromolar,3391157,>,40,0,>,,HC10,uM,,20.0,CHEMBL4296518,,Erythrocyte,,,,HC10,uM,UO_0000064,,20.0
102494,,Median N= 2; Maxinhib 9.0 Pct,20239371,[],CHEMBL4296191,"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)",F,,,BAO_0000187,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4513161,,,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3391157,>,40,1,>,,CC50,nM,,20000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,CC50,uM,UO_0000065,,20.0
102495,,,20644469,[],CHEMBL4613869,Inhibition of Mycobacterium smegmatis ATCC 607 dihydrofolic reductase,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4613212,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.16,0,http://www.openphacts.org/units/Nanomolar,3474716,=,1,1,=,,Ki,nM,,70.0,CHEMBL612545,,Unchecked,,,,Ki,10'-8M,UO_0000065,,7.0
102496,,,20644482,[],CHEMBL4613870,Inhibition of Mycobacterium smegmatis ATCC 607 dihydrofolic reductase assessed as ratio of Km to Ki,B,,,BAO_0000193,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4613212,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3474716,=,1,0,=,,Ratio,,,54.6,CHEMBL612545,,Unchecked,,,,Ratio,,,,54.6
102497,,,20644495,[],CHEMBL4613871,Antimicrobial activity against Mycobacterium smegmatis ATCC 607,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4613212,Bioorg Med Chem,2019.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3474716,=,1,1,=,,MIC,nM,,34000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,nmol/ml,UO_0000065,,34.0
102498,,,20659334,[],CHEMBL4617989,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI based susceptibility test method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4616637,J Nat Prod,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478297,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102499,,,20659343,[],CHEMBL4617990,Antibacterial activity against methicillin-resistant Staphylococcus aureus shhsA1 by CLSI based susceptibility test method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4616637,J Nat Prod,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478297,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
102500,,,20659352,[],CHEMBL4617991,Antibacterial activity against Bacillus subtilis 1064 by CLSI based susceptibility test method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4616637,J Nat Prod,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478297,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.25
102501,,,20659361,[],CHEMBL4617992,Antibacterial activity against Micrococcus luteus SCSIO ML01 by CLSI based susceptibility test method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4616637,J Nat Prod,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478297,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
102502,,,20660082,[],CHEMBL4618102,Antibacterial activity against Bacillus subtilis 168 after 12 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4616656,J Nat Prod,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.52,0,http://www.openphacts.org/units/Nanomolar,3478528,=,1,1,=,,IC50,nM,,300.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IC50,uM,UO_0000065,,0.3
102503,,,20691600,[],CHEMBL4625598,Inhibition of recombinant Mycobacterium tuberculosis DHFR expressed in Escherichia coli BL21(DE3) cells using DHF as substrate and NADPH as cofactor by fluorimetric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4622960,Bioorg Med Chem,2020.0,"{'bei': '13.97', 'le': '0.26', 'lle': '2.80', 'sei': '3.84'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.06,0,http://www.openphacts.org/units/Nanomolar,3485113,=,1,1,=,,IC50,nM,,88000.0,CHEMBL6065,Mycobacterium tuberculosis,Dihydrofolate reductase,1773.0,,,IC50,uM,UO_0000065,91.0,88.0
102504,,,22072228,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495565,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3360738,=,52,1,=,,Inhibition,%,,-0.03,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.03
102505,,,22075762,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4495565,,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3364272,=,52,1,=,,Inhibition,%,,-0.04,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.04
102506,,No. Measurements = 1,22081274,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4651402,,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3491029,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
102507,,No. Measurements = 1,22081275,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4651402,,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3491029,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
102508,,,22422081,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4673751,Inhibition of recombinant Mycobacterium ulcerans N-terminal His-tagged DHFR C89S mutant expressed in Escherichia coli BL21 (DE3)R3 rosetta cells using DiHF as substrate incubated for 30 mins by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3513732,>,1,1,>,,IC50,nM,,5000000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,5000.0
102509,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422082,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL4673752,Inhibition of recombinant Escherichia coli DHFR expressed in Escherichia coli BL21 (DE3) using DiHF as substrate incubated for 5 mins,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,9.7,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,Ki,nM,,0.2,CHEMBL612545,,Unchecked,,,,Ki,nM,UO_0000065,,0.2
102510,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL4673752,Inhibition of recombinant Escherichia coli DHFR expressed in Escherichia coli BL21 (DE3) using DiHF as substrate incubated for 5 mins,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,10.7,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,IC50,nM,,0.02,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,0.02
102511,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422084,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.05', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '3.0'}]",CHEMBL4673753,Inhibition of recombinant Mycobacterium tuberculosis DHFR expressed in Escherichia coli BL21 (DE3) using DiHF as substrate incubated for 3 mins by spectrophotometry,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.82,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,Ki,nM,,1500.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,1.5
102512,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422085,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.05', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '3.0'}]",CHEMBL4673753,Inhibition of recombinant Mycobacterium tuberculosis DHFR expressed in Escherichia coli BL21 (DE3) using DiHF as substrate incubated for 3 mins by spectrophotometry,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.78,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,IC50,nM,,16.5,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,16.5
102513,,,22422088,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4673754,Inhibition of recombinant Mycobacterium ulcerans N-terminal His-tagged DHFR expressed in Escherichia coli BL21 (DE3)R3 rosetta cells using DiHF as substrate incubated for 30 mins by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3513732,>,1,1,>,,IC50,nM,,8000.0,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,8000.0
102514,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422089,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.05', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '3.0'}]",CHEMBL4673755,Inhibition of recombinant Staphylococcus aureus His-tagged DHFR using DiHF as substrate incubated for 3 mins,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.36,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,Ki,nM,,4.4,CHEMBL612545,,Unchecked,,,,Ki,nM,UO_0000065,,4.4
102515,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22422090,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.05', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '3.0'}]",CHEMBL4673755,Inhibition of recombinant Staphylococcus aureus His-tagged DHFR using DiHF as substrate incubated for 3 mins,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673195,RSC Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,10.85,0,http://www.openphacts.org/units/Nanomolar,3513732,=,1,1,=,,IC50,nM,,0.014,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,0.0139999999999999
102516,,,22446485,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4679649,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4673388,ACS Med Chem Lett,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3517990,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
102517,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900761,[],CHEMBL4731690,Inhibition of bacterial DfrB1 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.42,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,380.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.38
102518,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900766,[],CHEMBL4731691,Inhibition of bacterial DfrB2 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.09,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,810.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.81
102519,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900771,[],CHEMBL4731692,Inhibition of bacterial DfrB3 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.35,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,450.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.45
102520,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900776,[],CHEMBL4731693,Inhibition of bacterial DfrB4 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.3,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,500.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.5
102521,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900781,[],CHEMBL4731694,Inhibition of bacterial DfrB5 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.89,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,1300.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,1.3
102522,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900786,[],CHEMBL4731695,Inhibition of bacterial DfrB7 expressed in Escherichia coli BL21 (DE3) using dihydrofolate and NADPH as substrate,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.18,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,660.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.66
102523,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22900789,[],CHEMBL4731697,Inhibition of Escherichia coli chromosomal Dfr,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4725477,ACS Med Chem Lett,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,10.7,0,http://www.openphacts.org/units/Nanomolar,3554917,=,1,1,=,,Ki,nM,,0.02,CHEMBL612545,,Unchecked,,,,Ki,pM,UO_0000065,,20.0
102524,,,22910758,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '10.0'}]",CHEMBL4734231,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732090,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3557244,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.0
102525,,,22910821,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '10.0'}]",CHEMBL4734234,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732090,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3557244,=,1,1,=,,IZ,mm,,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,0.0
102526,,,22910843,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '10.0'}]",CHEMBL4734235,Antifungal activity against Candida albicans ATCC 90028 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732090,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Millimeter,3557244,=,1,1,=,,IZ,mm,,0.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,DIZ,mm,UO_0000016,,0.0
102527,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22912046,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL4734505,Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732097,Eur J Med Chem,2021.0,"{'bei': '16.15', 'le': '0.30', 'lle': '3.43', 'sei': '4.44'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.69,0,http://www.openphacts.org/units/Nanomolar,3557392,=,1,1,=,,IC50,nM,,20500.0,CHEMBL4614,Leishmania major,Dihydrofolate reductase,5664.0,,,IC50,uM,UO_0000065,,20.5
102528,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22912061,[],CHEMBL4734506,Inhibition of recombinant human DHFR measured by spectrophotometric method,A,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732097,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,5.99,0,http://www.openphacts.org/units/Nanomolar,3557392,=,1,1,=,,IC50,nM,,1030.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,IC50,uM,UO_0000065,,1.03
102529,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22912104,[],CHEMBL4734510,Inhibition of Leishmania major DHFR assessed by NADPH oxidation measured by spectrophotometric method,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732097,Eur J Med Chem,2021.0,"{'bei': '23.84', 'le': '0.45', 'lle': '5.66', 'sei': '6.56'}",CHEMBL22,TRIMETHOPRIM,CHEMBL22,6.92,0,http://www.openphacts.org/units/Nanomolar,3557392,=,1,1,=,,Ki,nM,,120.0,CHEMBL4614,Leishmania major,Dihydrofolate reductase,5664.0,,,Ki,uM,UO_0000065,,0.12
102530,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22912109,[],CHEMBL4734511,Inhibition of human DHFR assessed by NADPH oxidation measured by spectrophotometric method,A,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4732097,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.0,1,http://www.openphacts.org/units/Nanomolar,3557392,=,1,1,=,,Ki,nM,,10.0,CHEMBL202,Homo sapiens,Dihydrofolate reductase,9606.0,,,Ki,uM,UO_0000065,,0.01
102531,,,23130136,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4808148,,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3592553,=,59,1,=,,Inhibition,%,,-29.75,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-29.75
102532,,,23135978,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4808148,,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3592553,=,59,1,=,,Inhibition,%,,-5.72,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-5.72
102533,"{'action_type': 'STABILISER', 'description': 'Increases the conformational stability of a protein or complex', 'parent_type': 'OTHER'}",,23262873,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '400.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '400.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4833456,Inhibition of 8-anilinonaphthalene-l-sulfonic acid binding to TTR V3OM mutant (unknown origin) expressed in Escherichia coli assessed as ANS saturation ratio at 400 uM incubated for 1 hr in presence of 7.5 uM ANS by fluorescence method (Rvb = 56 +/- 2.3%),B,P02766,V50M,BAO_0001103,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3619125,=,1,0,=,,Activity,%,,53.0,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,53.0
102534,"{'action_type': 'STABILISER', 'description': 'Increases the conformational stability of a protein or complex', 'parent_type': 'OTHER'}",,23262916,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '400.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '400.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4833457,Inhibition of 8-anilinonaphthalene-l-sulfonic acid binding to TTR V3OM mutant (unknown origin) expressed in Escherichia coli at 400 uM incubated for 1 hr in presence of 75 uM ANS by fluorescence method (Rvb = 91 +/- 0.92%),B,P02766,V50M,BAO_0001103,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3619125,=,1,0,=,,Activity,%,,90.0,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,90.0
102535,,,23262969,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '4.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '4.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '1.0'}]",CHEMBL4833459,Stabilization of TTR V3OM mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio at 4 uM incubated for 1 week by absorbance method,B,P02766,V50M,BAO_0001103,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3619125,=,1,0,=,,Activity,%,,7.0,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,7.0
102536,,,23263012,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '1.0'}]",CHEMBL4833460,Stabilization of TTR V3OM mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio at 10 uM incubated for 1 week by absorbance method,B,P02766,V50M,BAO_0001103,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3619125,=,1,0,=,,Activity,%,,-0.44,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,-0.44
102537,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880196,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL5155783,Inhibition of Escherichia coli C-terminal hexahistidine tagged DHFR at 5 uM incubated for 5 mins in presence of NADPH by measuring oxidation of NADPH to NADP+,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://qudt.org/vocab/unit#Percent,3888209,=,1,1,=,,Inhibition,%,,103.28,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,103.28
102538,,,24880207,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155784,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
102539,,,24880219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155785,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
102540,,,24880230,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155786,Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
102541,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880234,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL5155787,Inhibition of Escherichia coli C-terminal hexahistidine tagged DHFR incubated for 5 mins in presence of NADPH by measuring oxidation of NADPH to NADP+,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,7.21,0,http://www.openphacts.org/units/Nanomolar,3888209,=,1,1,=,,IC50,nM,,61.6,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,61.6
102542,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880238,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mM', 'standard_value': '0.2', 'text_value': None, 'type': 'Dose', 'units': 'mM', 'value': '0.2'}]",CHEMBL5155788,Binding affinity to Escherichia coli C-terminal hexahistidine tagged DHFR assessed as change in enthalpy at 0.2 mM by isothermal titration calorimetry method,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,=,1,0,=,,deltaH,cal/mol,,-1350.0,CHEMBL612545,,Unchecked,,,,deltaH,cal/mol,,,-1350.0
102543,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880242,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mM', 'standard_value': '0.2', 'text_value': None, 'type': 'Dose', 'units': 'mM', 'value': '0.2'}]",CHEMBL5155789,Binding affinity to Escherichia coli C-terminal hexahistidine tagged DHFR assessed as change in entropy at 0.2 mM by isothermal titration calorimetry method,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,=,1,0,=,,deltaS,cal/mol/deg,,-8.4,CHEMBL612545,,Unchecked,,,,deltaS,cal/mol/deg,,,-8.4
102544,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880246,[],CHEMBL5155790,Binding affinity to Escherichia coli C-terminal hexahistidine tagged DHFR assessed as dissociation constant by isothermal titration calorimetry method,B,,,BAO_0000034,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,8.06,0,http://www.openphacts.org/units/Nanomolar,3888209,=,1,1,=,,Kd,nM,,8.7,CHEMBL612545,,Unchecked,,,,Kd,nM,UO_0000065,,8.7
102545,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24880250,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mM', 'standard_value': '0.2', 'text_value': None, 'type': 'Dose', 'units': 'mM', 'value': '0.2'}]",CHEMBL5155791,Binding affinity to Escherichia coli C-terminal hexahistidine tagged DHFR assessed as change in gibbs free energy at 0.2 mM by isothermal titration calorimetry method,B,,,BAO_0000179,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,=,1,0,=,,deltaG,cal/mol,,-10984.3,CHEMBL612545,,Unchecked,,,,deltaG,cal/mol,,,-10984.3
102546,,,24880254,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155792,Antibacterial activity against multi drug resistant Acinetobacter baumannii CCPM(A)-100902 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
102547,,,24880258,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155793,Antibacterial activity against multi drug resistant Acinetobacter baumannii CCPM(A)-100903 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
102548,,,24880262,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155794,Antibacterial activity against multi drug resistant Acinetobacter baumannii CCPM(A)-1100708 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
102549,,,24880266,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155795,Antibacterial activity against Acinetobacter baumannii CCPM(A)-100946 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
102550,,,24880270,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155796,Antibacterial activity against Acinetobacter baumannii CCPM(A)-100947 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
102551,,,24880274,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155797,Antibacterial activity against ESBL-producing Klebsiella pneumoniae CCPM(A)-081514 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
102552,,,24880279,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155798,Antibacterial activity against ESBL-producing Klebsiella pneumoniae CCPM(A)-081568 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
102553,,,24880283,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155799,Antibacterial activity against Klebsiella pneumoniae CCPM(A)-081018 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
102554,,,24880287,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155800,Antibacterial activity against Escherichia coli CCPM(A)-0715118 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
102555,,,24880291,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155801,Antibacterial activity against ESBL-producing Escherichia coli CCPM(A)-071030 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
102556,,,24880295,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155802,Antibacterial activity against ESBL-producing Escherichia coli CCPM(A)-0715117 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
102557,,,24880299,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155803,Antibacterial activity against ESBL-producing Escherichia coli CCPM(A)-0715142 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
102558,,,24880303,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155804,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102559,,,24880307,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155805,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102560,,,24880311,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155806,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.5
102561,,,24880315,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155807,Antibacterial activity against Escherichia coli ATCC 25922 overexpressing DHFR assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
102562,,,24880326,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IV', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IV', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5155818,"In vivo Antibacterial activity against Escherichia coli ATCC 25922 in septicemia ICR mouse model assessed as reduction in bacterial load at 50 mg/kg, iv measured after 4 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,=,1,0,=,,Activity,CFU/ml,,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,CFU/ml,,,1000.0
102563,,,24880330,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5155820,Binding affinity to Escherichia coli TN-terminal hexahistidine-tagged TS at 20 uM by biolayer interferometry assay,B,,,BAO_0000375,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,,1,0,,,Activity,,,,CHEMBL2555,Escherichia coli K-12,Thymidylate synthase,83333.0,,,Activity,,,,
102564,,,24880337,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155821,Antibacterial activity against ESBL-producing Klebsiella pneumoniae ATCC 700603 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
102565,,,24880341,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155822,Antibacterial activity against Escherichia coli ATCC 25922 assessed as blockage of folate pathway after 16 to 18 hrs in presence of thymine by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3888209,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
102566,,,24880346,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155824,Antibacterial activity against Escherichia coli ATCC 25922 overexpressing DHFR assessed as fold increase in MIC after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,>,1,0,>,,FC,,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,512.0
102567,,,24880350,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5155825,Antibacterial activity against Escherichia coli ATCC 25922 assessed as blockage of folate pathway after 16 to 18 hrs in presence of thymine by measuring fold increase in MIC by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154653,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3888209,>,1,0,>,,FC,,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,512.0
102568,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24902192,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '7.0'}]",CHEMBL5161038,Inhibition of Escherichia coli DHFR preincubated with NADPH for 3 mins followed by compound addition for 7 mins by colorimetric assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154785,J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,9.0,0,http://www.openphacts.org/units/Nanomolar,3891946,=,1,1,=,,IC50,nM,,1.0,CHEMBL612545,,Unchecked,,,,IC50,nM,UO_0000065,,1.0
102569,,,24902193,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5161039,Antibacterial activity against Escherichia coli CS1562 assessed as reduction in bacterial growth measured after 24 hrs by plate reader method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5154785,J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3891946,=,1,1,=,,MIC,nM,,1300.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.3
102570,,,25000336,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232878,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
102571,,,25000366,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232879,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
102572,,,25000396,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232880,Antibacterial activity against clinical isolate methicillin resistant Staphylococcus epidermidis AB 735 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
102573,,,25000426,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232881,Antibacterial activity against vancomycin resistant Enterococcus faecalis ATCC 700802 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
102574,,,25000456,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232882,Antibacterial activity against Enterococcus faecium ATCC 49624 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
102575,,,25000486,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232883,Antibacterial activity against clinical isolate Escherichia coli AB 117 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
102576,,,25000516,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232884,Antibacterial activity against clinical isolate Klebsiella pneumoniae AB 356 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
102577,,,25000546,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232885,Antibacterial activity against clinical isolate Pseudomonas aeruginosa AB 645 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
102578,,,25000576,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232886,Antibacterial activity against clinical isolate Acinetobacter baumannii BAA 747 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
102579,,,25000606,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232887,Antibacterial activity against Moraxella catarrhalis ATCC 25238 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911002,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,4.0
102580,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25004841,[],CHEMBL5234374,Inhibition of Pseudomonas aeruginosa DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.05,0,http://www.openphacts.org/units/Nanomolar,3912554,=,1,1,=,,IC50,nM,,88700.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,88.7
102581,,,25004850,[],CHEMBL5234375,Antibacterial activity against Pseudomonas aeruginosa PA01,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3912554,=,1,1,=,,MIC,nM,,110000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,110.0
102582,,,25004856,[],CHEMBL5234380,Additive antibacterial activity against Pseudomonas aeruginosa PA01 assessed as fractional inhibitory concentration index in presence of protocatechuic acid,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3912554,=,1,0,=,,FICI,,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,1.0
102583,,,25004857,[],CHEMBL5234381,Additive antibacterial activity against Pseudomonas aeruginosa PA01 assessed as fractional inhibitory concentration index in presence of gallic acid,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3912554,=,1,0,=,,FICI,,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,1.0
102584,,,25004858,[],CHEMBL5234382,Additive antibacterial activity against Pseudomonas aeruginosa PA01 assessed as fractional inhibitory concentration index in presence of quercetin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3912554,=,1,0,=,,FICI,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,2.0
102585,,,25004859,[],CHEMBL5234383,Additive antibacterial activity against Pseudomonas aeruginosa PA01 assessed as fractional inhibitory concentration index in presence of myricetin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5233242,Eur J Med Chem,2020.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3912554,=,1,0,=,,FICI,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,2.0
102586,,,25018510,[],CHEMBL5238882,Antibacterial activity against trimethoprim sensitive Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,=,1,1,=,,MIC,nM,,6250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,6.25
102587,,,25018515,[],CHEMBL5238883,Antibacterial activity against trimethoprim resistant Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,=,1,1,=,,MIC,nM,,12500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,12.5
102588,,,25018520,[],CHEMBL5238884,Antibacterial activity against trimethoprim sensitive Enterococcus faecium assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,=,1,1,=,,MIC,nM,,780.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,0.78
102589,,,25018525,[],CHEMBL5238885,Antibacterial activity against trimethoprim resistant Enterococcus faecium assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,=,1,1,=,,MIC,nM,,100000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,100.0
102590,,,25018530,[],CHEMBL5238886,Antibacterial activity against trimethoprim sensitive Acinetobacter baumannii assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,=,1,1,=,,MIC,nM,,6250.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,6.25
102591,,,25018535,[],CHEMBL5238887,Antibacterial activity against trimethoprim resistant Acinetobacter baumannii assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5236604,Bioorg Med Chem Lett,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3916205,>,1,1,>,,MIC,nM,,400000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,400.0
102592,,,25029846,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5241305,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as bacterial growth inhibition incubated for 24 hrs by ELISA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918669,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
102593,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25030440,[],CHEMBL5241541,Inhibition of Brugia malayi DHFR,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5241068,Eur J Med Chem,2021.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,4.89,0,http://www.openphacts.org/units/Nanomolar,3918956,=,1,1,=,,IC50,nM,,12920.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,12.92
102594,,Toxic,25059812,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250144,"Toxicity in BALB/c mouse assessed as increase in liver weight at 20 mg/kg, po administered for 5 days and measured after 1 day",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102595,,Non-Toxic,25059817,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250147,"Toxicity in BALB/c mouse assessed as changes in liver weight at 20 mg/kg, po administered for 5 days and measured after 14 days",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102596,,Non-Toxic,25059823,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250150,"Toxicity in BALB/c mouse assessed as increase in serum AST level at 20 mg/kg, po administered for 5 days and measured on day 1 and day 14 by ELISA method",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102597,,Non-Toxic,25059827,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250152,"Toxicity in BALB/c mouse assessed as increase in serum ALT level at 20 mg/kg, po administered for 5 days and measured on day 1 and day 14 by ELISA method",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102598,,Toxic,25059832,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250156,"Toxicity in BALB/c mouse assessed as increase in creatinine level at 20 mg/kg, po administered for 5 days and measured after 1 day by colorimetric assay",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102599,,Toxic,25059838,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250160,"Toxicity in BALB/c mouse assessed as hydropic degeneration at 20 mg/kg, po administered for 5 days and measured after 1 day by hematoxylin-eosin staining based microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102600,,Toxic,25059845,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250163,"Toxicity in BALB/c mouse assessed as disseminated necrosis of hepatocytes at 20 mg/kg, po administered for 5 days and measured after 1 day by hematoxylin-eosin staining based microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102601,,Toxic,25059851,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250168,"Toxicity in BALB/c mouse assessed as changes in size of hepatocyte nuclei at 20 mg/kg, po administered for 5 days and measured after 1 day by hematoxylin-eosin staining based microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102602,,Toxic,25059853,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250169,"Toxicity in BALB/c mouse assessed as changes in size of hepatocyte nuclei at 20 mg/kg, po administered for 5 days and measured after 14 days by hematoxylin-eosin staining based microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
102603,,Active,25059861,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250175,"Antiparasitic activity against Toxoplasma gondii RH infected in BALB/c mouse assessed as prolongation of animal survival at 20 mg/kg, po administered every 24 hrs for 5 days starting from 24 hrs post infection by Kaplan-Meier method",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,Activity,,,,
102604,,Not Active,25059869,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250180,"Antiparasitic activity against Toxoplasma gondii RH infected in BALB/c mouse assessed as decrease in IFNgamma level in serum at 20 mg/kg, po administered every 24 hrs for 5 days starting from 24 hrs post infection by ELISA method",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,Activity,,,,
102605,,Active,25059873,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250183,"Antiparasitic activity against Toxoplasma gondii RH infected in BALB/c mouse assessed as reduction of bradyzoite gene copies in brain at 20 mg/kg, po administered every 24 hrs for 5 days starting from 24 hrs post infection by real-time qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,Activity,,,,
102606,,,25059882,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250189,"Antiparasitic activity against Toxoplasma gondii RH infected in BALB/c mouse assessed as reduction in number of bradyzoite gene copies in muscles at 20 mg/kg, po administered every 24 hrs for 5 days starting from 24 hrs post infection by real-time qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,=,1,0,=,,Activity,,,36.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,Activity,,,,36.0
102607,,Active,25059887,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5250192,"Antiparasitic activity against Toxoplasma gondii DX infected in C3H/HeOuJ mouse assessed as prolongation of survival at 20 mg/kg, po administered every 24 hrs for 5 days starting from 24 hrs post infection by Kaplan-Meier method",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5247617,Eur J Med Chem,2022.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,,3927751,,1,0,,,Activity,,,,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,Activity,,,,
102608,,,25091311,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5258339,Antibacterial activity against Acinetobacter baumannii ATCC 19606 measured after 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5257052,J Nat Prod,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934050,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.125
102609,,,25091320,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5258340,Antibacterial activity against Vibrio alginolyticus 13214 measured after 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5257052,J Nat Prod,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934050,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,,MIC,ug ml-1,UO_0000274,,0.125
102610,,,25091329,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5258341,Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5257052,J Nat Prod,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934050,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102611,,,25091338,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5258342,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 measured after 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5257052,J Nat Prod,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934050,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
102612,,,25091347,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5258343,Antibacterial activity against Micrococcus luteus SCSIO ML01 measured after 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5257052,J Nat Prod,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934050,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
102613,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25114466,[],CHEMBL5291811,Binding affinity towards human HRH2 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102614,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25114752,[],CHEMBL5291902,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102615,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25116628,[],CHEMBL5291807,Agonist activity at human HRH1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102616,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25116981,[],CHEMBL5291808,Antagonist activity at human HRH1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102617,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117973,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
102618,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119649,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
102619,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120675,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,10.0
102620,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121848,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102621,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122927,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102622,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124023,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
102623,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126167,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,10.0
102624,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127401,[],CHEMBL5291783,Binding affinity towards human DRD4 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102625,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128096,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
102626,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128767,[],CHEMBL5291884,Binding affinity towards human TACR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102627,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129491,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102628,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130667,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
102629,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131878,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102630,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133078,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102631,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134282,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102632,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25135526,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,10.0
102633,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136757,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,10.0
102634,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137978,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102635,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25139652,[],CHEMBL5291754,Compound was evaluated for inhibition of rat Cacna1b in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL5107,Rattus norvegicus,Voltage-gated N-type calcium channel alpha-1B subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
102636,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140406,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102637,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141608,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,30.0
102638,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25143773,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102639,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145072,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
102640,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147948,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102641,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149195,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102642,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150406,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
102643,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25152551,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102644,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153329,[],CHEMBL5291743,Binding affinity towards human ADRB3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102645,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153508,[],CHEMBL5291806,Binding affinity towards human HCAR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3785,Homo sapiens,Hydroxycarboxylic acid receptor 2,9606.0,,,AC50,uM,UO_0000065,,10.0
102646,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154139,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102647,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155266,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102648,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155972,[],CHEMBL5291893,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102649,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25157498,[],CHEMBL5291894,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102650,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159750,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,10.0
102651,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25161469,[],CHEMBL5291804,Binding affinity towards human GIPR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4383,Homo sapiens,Gastric inhibitory polypeptide receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102652,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162190,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102653,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163329,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102654,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25164141,[],CHEMBL5291822,Binding affinity towards human HTR2B in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102655,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25164534,[],CHEMBL5291896,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102656,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166260,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,30.0
102657,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167373,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
102658,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169404,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102659,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170519,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102660,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171497,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102661,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172096,[],CHEMBL5291802,Binding affinity towards human GCGR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1985,Homo sapiens,Glucagon receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102662,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172825,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102663,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173645,[],CHEMBL5291818,Binding affinity towards human HTR2A in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102664,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174466,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,30.0
102665,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175239,[],CHEMBL5291793,Binding affinity towards human ESR2 in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,AC50,uM,UO_0000065,,30.0
102666,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175912,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102667,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177061,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102668,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178277,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102669,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179272,[],CHEMBL5291785,Binding affinity towards human EDNRA in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,AC50,uM,UO_0000065,,30.0
102670,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179860,[],CHEMBL5291786,Binding affinity towards human EDNRB in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1785,Homo sapiens,Endothelin receptor ET-B,9606.0,,,AC50,uM,UO_0000065,,30.0
102671,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180590,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102672,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181671,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102673,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182155,[],CHEMBL5291752,Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4308,Homo sapiens,Bradykinin B1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102674,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182450,[],CHEMBL5291775,Binding affinity towards human CRHR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1800,Homo sapiens,Corticotropin releasing factor receptor 1,9606.0,,,AC50,uM,UO_0000065,,30.0
102675,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182735,[],CHEMBL5291776,Binding affinity towards human CRHR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4069,Homo sapiens,Corticotropin releasing factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
102676,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183470,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
102677,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184459,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,30.0
102678,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25185400,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
102679,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186585,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
102680,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187498,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
102681,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189257,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102682,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190014,[],CHEMBL5291851,Binding affinity towards human NTSR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4123,Homo sapiens,Neurotensin receptor 1,9606.0,,,AC50,uM,UO_0000065,,30.0
102683,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190765,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
102684,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192502,[],CHEMBL5291835,Binding affinity towards human NPY2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,AC50,uM,UO_0000065,,30.0
102685,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192832,[],CHEMBL5291862,Binding affinity towards human PGR in an in vitro cell free assay measured by fluorescence polarization method in vitro cell free assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102686,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193599,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102687,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195291,[],CHEMBL5291900,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
102688,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25200653,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102689,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212584,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102690,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213806,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
102691,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215009,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
102692,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216071,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102693,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217087,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102694,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218121,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102695,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25219960,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102696,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221157,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102697,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225236,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102698,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25226403,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102699,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227591,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102700,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228784,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
102701,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229865,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102702,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230793,[],CHEMBL5291772,Antagonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102703,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231679,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102704,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25233614,[],CHEMBL5291741,Agonist activity at human ADRB2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL22,TRIMETHOPRIM,CHEMBL22,,0,http://www.openphacts.org/units/Nanomolar,3941233,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
102705,,,1299859,[],CHEMBL821353,Association constant with ferriprotoporphyrin IX.,B,,,BAO_0000179,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1133112,J Med Chem,2000.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,,183299,<,1,0,<,,Log K,,,2.5,CHEMBL613897,Plasmodium falciparum,Ferriprotoporphyrin IX,5833.0,,,Log K,,,,2.5
102706,,No inhibition,1299860,[],CHEMBL842728,Inhibition of Beta-hematin (hemozoin) formation; No inhibition.,B,,,BAO_0000179,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1133112,J Med Chem,2000.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,,183299,,1,0,,,NI,,,,CHEMBL1923,Plasmodium falciparum,Histidine-rich protein,5833.0,,,NI,,,,
102707,,,1299861,[],CHEMBL765487,In vitro antiplasmodial activity against Plasmodium falciparum D10,F,,,BAO_0000190,BAO_0000218,organism-based format,Nc1cccc2cccnc12,,,CHEMBL1133112,J Med Chem,2000.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,183299,>,1,1,>,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,nM,UO_0000065,,10000.0
102708,,,2030917,[],CHEMBL886434,"Partition coefficient, log P of the compound",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,Nc1cccc2cccnc12,,,CHEMBL1139964,Eur J Med Chem,2007.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,,674251,=,1,1,=,,LogP,,,1.79,CHEMBL2362975,,No relevant target,,,,LogP,,,,1.79
102709,,,2030935,[],CHEMBL886435,Solubility in water,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,Nc1cccc2cccnc12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139964,Eur J Med Chem,2007.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,674251,=,1,1,=,,Solubility,ug.mL-1,,8220000.0,CHEMBL2362975,,No relevant target,,,,Solubility,10^3g/L,UO_0000274,,8.22
102710,,Not Active,3684551,[],CHEMBL1613874,PUBCHEM_BIOASSAY: Tumor Hsp90 Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)],F,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1087861,>,7,1,>,,IC50,nM,,50000.0,CHEMBL2095165,Homo sapiens,Heat shock protein HSP90,9606.0,,,IC50,um,UO_0000065,,50.0
102711,,Not Active,3684655,[],CHEMBL1613874,PUBCHEM_BIOASSAY: Tumor Hsp90 Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)],F,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1087923,>,7,1,>,,IC50,nM,,50000.0,CHEMBL2095165,Homo sapiens,Heat shock protein HSP90,9606.0,,,IC50,um,UO_0000065,,50.0
102712,,,5193587,[],CHEMBL1664432,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,51.0,CHEMBL333,Homo sapiens,Matrix metalloproteinase-2,9606.0,,,INH,%,UO_0000187,,51.0
102713,,,5193594,[],CHEMBL1664430,Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,30.0,CHEMBL4372,Bacillus anthracis,Anthrax lethal factor,1392.0,,,INH,%,UO_0000187,,30.0
102714,,,5193689,[],CHEMBL1664433,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,56.0,CHEMBL283,Homo sapiens,Matrix metalloproteinase 3,9606.0,,,INH,%,UO_0000187,,56.0
102715,,,5194087,[],CHEMBL1664428,Inhibition of mushroom tyrosinase at 1 mM after 10 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,-59.0,CHEMBL3318,Agaricus bisporus,Tyrosinase,5341.0,,,INH,%,UO_0000187,,-59.0
102716,,,5194282,[],CHEMBL1664431,Inhibition of human recombinant MMP1 at 1 mM after 30 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,63.0,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,INH,%,UO_0000187,,63.0
102717,,,5194284,[],CHEMBL1664434,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,61.0,CHEMBL4588,Homo sapiens,Matrix metalloproteinase 8,9606.0,,,INH,%,UO_0000187,,61.0
102718,,,5194287,[],CHEMBL1664435,Inhibition of human recombinant MMP9 at 1 mM after 30 mins,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL1649420,J Med Chem,2011.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,1323416,=,1,1,=,,Inhibition,%,,57.0,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,INH,%,UO_0000187,,57.0
102719,,inactive,6569779,[],CHEMBL1794394,"PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029]",F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1484973,>,7,1,>,,IC50,nM,,79000.0,CHEMBL397,Homo sapiens,Jurkat,9606.0,,,IC50,uM,UO_0000065,,79.0
102720,,inconclusive,6943349,[],CHEMBL1794483,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],F,,,BAO_0000186,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1491625,,7,1,,,Potency,nM,,89125.1,CHEMBL5391,Homo sapiens,DNA polymerase iota,9606.0,,,Potency,uM,UO_0000065,,89.1251
102721,,inactive,6962364,[],CHEMBL1794563,"PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029]",F,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1484973,>,7,1,>,,IC50,nM,,79000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,79.0
102722,,inactive,7017109,[],CHEMBL1794553,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860]",F,,,BAO_0000186,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1491625,,7,1,,,Potency,nM,,10000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Potency,uM,UO_0000065,,10.0
102723,,inactive,7337394,[],CHEMBL1794374,"PUBCHEM_BIOASSAY: SAR analysis of small molecule cytotoxicity in HEK293 cells for activators of NF-kappaB using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID435022, AID435025]",F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1484973,>,7,1,>,,IC50,nM,,80000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,IC50,uM,UO_0000065,,80.0
102724,,inactive,7461621,[],CHEMBL1794421,"PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489019, AID489029]",F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1484973,>,7,1,>,,IC50,nM,,79000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,IC50,uM,UO_0000065,,79.0
102725,,active,12916086,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1491625,,7,1,,,Potency,nM,,5623.4,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,5.6234
102726,,active,13000104,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1491625,,7,1,,,Potency,nM,,1778.3,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.7783
102727,,inconclusive,14064089,[],CHEMBL3215017,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1cccc2cccnc12,,,CHEMBL1201862,,,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,1491625,,7,1,,,Potency,nM,,2818.4,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,2.8184
102728,,413021,17777736,[],CHEMBL3888734,"Enzymatic Assay: Enzymatic activity is measured by contacting the enzyme with a suitable substrate, such as fructose 1,6-bisphosphate, and measuring formation of a product such as dihydroxyacetone phosphate (DHAP) or glyceraldehyde 3-phosphate (GAP). If the activity is measurably lower in the presence of the candidate compound than in its absence, then the compound has FBA inhibitory activity and is a candidate antibiotic and antiparasitic compound. The compound may also be screened with recombinant or isolated Class I FBA (for example, of human or mammalian origin) to determine cross-inhibition.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL3886809,,2016.0,"{'bei': '28.45', 'le': '0.51', 'lle': '2.28', 'sei': '10.54'}",CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,4.1,0,http://www.openphacts.org/units/Nanomolar,2886726,=,37,1,=,,IC50,nM,,79000.0,CHEMBL1287620,Mycobacterium tuberculosis,Fructose-bisphosphate aldolase,1773.0,,,IC50,nM,UO_0000065,,79000.0
102729,,,18229011,[],CHEMBL4049704,Inhibition of 26S proteasome regulatory subunit RPN11 deubiquitinating activity in human erythrocytes using Ub4-pepOG protein substrate preincubated for 1 hr followed by substrate addition measured after 80 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL4049386,J Med Chem,2017.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,3024956,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2007629,Homo sapiens,26S proteasome non-ATPase regulatory subunit 14,9606.0,,,IC50,uM,UO_0000065,,100.0
102730,,,19155447,[],CHEMBL4381025,Covalent inhibition of recombinant human His-tagged p47phox SH3A-B domain (151 to 285 residues) expressed in Escherichia coli BL21 (DE3) cells interaction with Cy5-p22phox149-162 incubated for 10 mins by fluorescence polarization competition assay,B,,,BAO_0000192,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL4376880,J Med Chem,2020.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://www.openphacts.org/units/Nanomolar,3197015,>,1,1,>,,Ki,nM,,2000000.0,CHEMBL1613743,Homo sapiens,Neutrophil cytosol factor 1,9606.0,,,Ki,uM,UO_0000065,,2000.0
102731,,,19155631,[],CHEMBL4381034,Binding affinity to immobilized recombinant human His-tagged p47phox SH3A-B domain (151 to 285 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as maximal response by SPR assay relative to quinolin-2-amine,B,,,BAO_0000179,BAO_0000219,cell-based format,Nc1cccc2cccnc12,,,CHEMBL4376880,J Med Chem,2020.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,http://qudt.org/vocab/unit#Percent,3197015,<,1,0,<,,Rmax,%,,20.0,CHEMBL1613743,Homo sapiens,Neutrophil cytosol factor 1,9606.0,,,Rmax,%,UO_0000187,,20.0
102732,,,24861275,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '6.0'}]",CHEMBL5149905,Inhibition of recombinant human QC using H-Gln-AMC hydrobromide as fluorogenic substrate incubated for 6 hrs by fluorometric microplate reader analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc2cccnc12,,,CHEMBL5143758,ACS Med Chem Lett,2022.0,,CHEMBL99932,8-AMINOQUINOLINE,CHEMBL99932,,0,,3884094,,1,0,,,IC50,,,,CHEMBL4508,Homo sapiens,Glutaminyl-peptide cyclotransferase,9606.0,,,IC50,,,,
102733,,,979642,[],CHEMBL755667,Inhibition of proliferation of murine P388 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1131501,J Med Chem,1998.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.84,0,http://www.openphacts.org/units/Nanomolar,2762,=,1,1,=,,IC50,nM,,14300.0,CHEMBL389,Mus musculus,P388,10090.0,,,IC50,uM,UO_0000065,,14.3
102734,,,979643,[],CHEMBL708788,Concentration required to inhibit 50% growth of L1210 leukemia cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1131501,J Med Chem,1998.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.42,0,http://www.openphacts.org/units/Nanomolar,2762,=,1,1,=,,IC50,nM,,37900.0,CHEMBL386,Mus musculus,L1210,10090.0,,,IC50,uM,UO_0000065,,37.9
102735,,,979644,[],CHEMBL696460,Concentration required to inhibit 50% growth of human Molt 4/C8 T-lymphocyte cells,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1131501,J Med Chem,1998.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.07,0,http://www.openphacts.org/units/Nanomolar,2762,=,1,1,=,,IC50,nM,,8580.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,IC50,uM,UO_0000065,,8.58
102736,,,979645,[],CHEMBL696907,Concentration required to inhibit 50% growth of Human CEM T-lymphocytes cells,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1131501,J Med Chem,1998.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.03,0,http://www.openphacts.org/units/Nanomolar,2762,=,1,1,=,,IC50,nM,,9310.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,IC50,uM,UO_0000065,,9.31
102737,,,1041573,[],CHEMBL749521,Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.,B,,,BAO_0000179,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1131595,J Med Chem,1998.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Micromolar,292851,=,1,0,=,,CD,uM,,33.0,CHEMBL4332,Mus musculus,Quinone oxidoreductase,10090.0,,,CD,uM,UO_0000064,,33.0
102738,,,1605684,[],CHEMBL872182,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1141069,J Med Chem,2005.0,"{'bei': '19.26', 'le': '0.35', 'lle': '1.03', 'sei': '11.58'}",CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.32,0,http://www.openphacts.org/units/Nanomolar,401731,=,1,1,=,,IC50,nM,,47863.01,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,pIC50,,UO_0000065,,4.32
102739,,Not Active,1661412,[],CHEMBL870545,Inhibitory activity against baker's yeast alpha glucosidase at 200 uM,B,,,BAO_0000375,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1141244,Bioorg Med Chem Lett,2005.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,410351,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
102740,,Not Active,1661423,[],CHEMBL870547,Inhibitory activity against Bacillus licheniformis alpha amylase at 200 uM,B,,,BAO_0000375,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1141244,Bioorg Med Chem Lett,2005.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,410351,,1,0,,,Activity,,,,CHEMBL4215,Bacillus licheniformis,Alpha-amylase,1402.0,,,Activity,,,,
102741,,Not Active,1661434,[],CHEMBL870548,Inhibitory activity against barley beta amylase at 200 uM,B,,,BAO_0000375,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1141244,Bioorg Med Chem Lett,2005.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,410351,,1,0,,,Activity,,,,CHEMBL4371,Hordeum vulgare,Beta-amylase,4513.0,,,Activity,,,,
102742,,,1860203,[],CHEMBL915956,Antifungal activity against Candida albicans Berhaut 62I after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1144480,Eur J Med Chem,2007.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632447,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,62.5
102743,,,1860246,[],CHEMBL915957,Growth inhibition of Candida albicans Berhaut 62I by agar cup method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1144480,Eur J Med Chem,2007.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Millimeter,632447,=,1,1,=,,IZ,mm,,15.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IZ,mm,UO_0000016,,15.0
102744,,,1860460,[],CHEMBL915958,Antifungal activity against Candida albicans Berhaut 62I in meat-pepton broth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1144480,Eur J Med Chem,2007.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632447,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,62.5
102745,,,2072879,[],CHEMBL928773,Blockade of human K+ channel in HEK293 cells assessed as inhibition of outward delayed rectifying K+ current,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1140789,Bioorg Med Chem Lett,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,687403,>,1,1,>,,IC50,nM,,50000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,50.0
102746,,,2303557,[],CHEMBL938937,Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 48 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1137684,Eur J Med Chem,2009.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Millimeter,783262,=,1,1,=,,IZ,mm,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,19.0
102747,,,2303608,[],CHEMBL938938,Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 24 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1137684,Eur J Med Chem,2009.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783262,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,125.0
102748,,Not Active,2304763,[],CHEMBL938936,Antibacterial activity against Escherichia coli WF+,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1137684,Eur J Med Chem,2009.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,783262,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
102749,,,2368902,[],CHEMBL989925,Antifungal activity against haploid Saccharomyces cerevisiae 1S by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102750,,,2368903,[],CHEMBL989926,Antifungal activity against diploid Saccharomyces cerevisiae PV-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102751,,,2368904,[],CHEMBL989927,Antifungal activity against diploid Saccharomyces cerevisiae PV-3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102752,,,2368905,[],CHEMBL989928,Antifungal activity against haploid Saccharomyces cerevisiae 1169 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102753,,,2368906,[],CHEMBL989929,Antifungal activity against haploid Saccharomyces cerevisiae 2180 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102754,,,2368907,[],CHEMBL989930,Antifungal activity against diploid Saccharomyces cerevisiae 1a by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102755,,,2368908,[],CHEMBL989931,Antifungal activity against diploid Saccharomyces cerevisiae 29a by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102756,,,2368909,[],CHEMBL989932,Antifungal activity against haploid Saccharomyces cerevisiae Sigma 1278b by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102757,,,2368910,[],CHEMBL989933,Antifungal activity against haploid Saccharomyces cerevisiae D3C by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102758,,,2368911,[],CHEMBL989934,Antifungal activity against haploid Saccharomyces cerevisiae FY4 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102759,,,2368912,[],CHEMBL989935,Antifungal activity against haploid Saccharomyces cerevisiae 10560-6B by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102760,,,2368913,[],CHEMBL989936,Antifungal activity against haploid Saccharomyces cerevisiae YSH1170 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102761,,,2368914,[],CHEMBL989937,Antifungal activity against haploid Saccharomyces cerevisiae YSH1171 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,40.0
102762,,,2368915,[],CHEMBL989938,Antifungal activity against Hansenula polymorpha WT1 with ade1 ura3 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102763,,,2368916,[],CHEMBL989939,Antifungal activity against Hansenula polymorpha WT2 with ade1 met6 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102764,,,2368917,[],CHEMBL989940,Antifungal activity against Hansenula polymorpha CD1 with ade1 leu2 cds1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102765,,,2368918,[],CHEMBL989941,Antifungal activity against Hansenula polymorpha CD2 with ade1 leu2 cds2 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102766,,,2368919,[],CHEMBL989942,Antifungal activity against Hansenula polymorpha CD3 with ade1 leu2 cds3 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102767,,,2368920,[],CHEMBL989943,Antifungal activity against Hansenula polymorpha WA1 with ade1 leu2 gsh1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102768,,,2368921,[],CHEMBL989944,Antifungal activity against Hansenula polymorpha 2a with arg1 leu2 ura3 cys1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102769,,,2368922,[],CHEMBL989945,Antifungal activity against Hansenula polymorpha 2b with arg1 ade1 leu2 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102770,,,2368923,[],CHEMBL989946,Antifungal activity against Hansenula polymorpha D22 with arg1/arg1 ade1/ADE1 leu2/leu2 URA3/ura3 CYS1/cys1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102771,,,2368924,[],CHEMBL989947,Antifungal activity against Hansenula polymorpha M2 with met2 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102772,,,2368925,[],CHEMBL989948,Antifungal activity against Hansenula polymorpha MC1 with met2 cys1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102773,,,2368926,[],CHEMBL989949,Antifungal activity against Hansenula polymorpha AS1 with arg1 gsh2delta genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102774,,,2368927,[],CHEMBL989950,Antifungal activity against Hansenula polymorpha M4 with met4 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102775,,,2368928,[],CHEMBL989951,Antifungal activity against Hansenula polymorpha AU05 with ade3 ura3 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102776,,,2368929,[],CHEMBL989952,Antifungal activity against Hansenula polymorpha CTA1 with leu2 cat1 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102777,,,2368930,[],CHEMBL989953,Antifungal activity against Hansenula polymorpha R3 with rgh3 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102778,,,2368931,[],CHEMBL990762,Antifungal activity against Hansenula polymorpha CRD2 with leu2 CDR2 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL613003,Ogataea angusta,Ogataea angusta,870730.0,,,MIC,ug ml-1,UO_0000274,,40.0
102779,,,2368932,[],CHEMBL990763,Antifungal activity against Kluyveromyces lactis 2-18B with MATalpha metA1 ura3 leu2 genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL612786,Kluyveromyces lactis,Kluyveromyces lactis,28985.0,,,MIC,ug ml-1,UO_0000274,,40.0
102780,,,2368933,[],CHEMBL990764,Antifungal activity against Kluyveromyces lactis 1-6A with MATalpha uraA lys arg genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL612786,Kluyveromyces lactis,Kluyveromyces lactis,28985.0,,,MIC,ug ml-1,UO_0000274,,40.0
102781,,,2368934,[],CHEMBL990765,Antifungal activity against Kluyveromyces lactis 2-19B with MATalpha ura lys arg genotype by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1158182,Eur J Med Chem,2008.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,774088,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL612786,Kluyveromyces lactis,Kluyveromyces lactis,28985.0,,,MIC,ug ml-1,UO_0000274,,40.0
102782,,,2985682,[],CHEMBL1037167,Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1156143,J Med Chem,2009.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,861057,>,1,1,>,,IC50,nM,,20000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,20.0
102783,,Not Active,3769740,[],CHEMBL1614410,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.2,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,63095.7,CHEMBL1293299,Homo sapiens,Histone-lysine N-methyltransferase MLL,9606.0,,,Potency,um,UO_0000065,,63.0957
102784,,Not Active,3802331,[],CHEMBL1613836,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.93,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,11668.1,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,Potency,um,UO_0000065,,11.6681
102785,,Inconclusive,3835827,[],CHEMBL1613838,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.2,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,6309.6,CHEMBL1293294,Homo sapiens,Ras-related protein Rab-9A,9606.0,,,Potency,um,UO_0000065,,6.3096
102786,,Active,3905831,[],CHEMBL1614285,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ],F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.9,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,12589.3,CHEMBL5149,Leishmania mexicana,Pyruvate kinase,5665.0,,,Potency,um,UO_0000065,,12.5893
102787,,Not Active,4058118,[],CHEMBL1614428,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.7,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,19952.6,CHEMBL1075189,Homo sapiens,Pyruvate kinase isozymes M1/M2,9606.0,,,Potency,um,UO_0000065,,19.9526
102788,,Inconclusive,4209881,[],CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.04,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,9200.0,CHEMBL612545,,Unchecked,,,,Potency,um,UO_0000065,,9.2
102789,,Not Active,4281029,[],CHEMBL1614120,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.9,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,12589.3,CHEMBL5149,Leishmania mexicana,Pyruvate kinase,5665.0,,,Potency,um,UO_0000065,,12.5893
102790,,Not Active,4434045,[],CHEMBL1614236,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.0,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,10000.0,CHEMBL1293303,Influenza A virus,Nonstructural protein 1,382835.0,,,Potency,um,UO_0000065,,10.0
102791,,Active,4534024,[],CHEMBL1614192,"PUBCHEM_BIOASSAY: Luminescence Biochemical Dose Response HTS to Identify Inhibitors of Luciferase. (Class of assay: confirmatory) [Related pubchem assays: 1663 (Primary HTS), 1678 (Summary of Project)]",B,,,BAO_0000188,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,<,7,1,<,,EC50,nM,,88.0,CHEMBL5567,Photinus pyralis,Luciferin 4-monooxygenase,7054.0,,,EC50,um,UO_0000065,,0.088
102792,,Active,4536896,[],CHEMBL1614201,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Platelet Dense Granule Release. (Class of assay: confirmatory) [Related pubchem assays: 1663 (Primary HTS), 1678 (Summary of Project)]",F,,,BAO_0000188,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,<,7,1,<,,EC50,nM,,701.0,CHEMBL612545,,Unchecked,,,,EC50,um,UO_0000065,,0.701
102793,,Inconclusive,4785671,[],CHEMBL1614087,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.75,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,17782.8,CHEMBL1293231,Mus musculus,Nuclear receptor ROR-gamma,10090.0,,,Potency,um,UO_0000065,,17.7828
102794,,Inconclusive,4823789,[],CHEMBL1613996,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ],F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.7,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,19952.6,CHEMBL1075189,Homo sapiens,Pyruvate kinase isozymes M1/M2,9606.0,,,Potency,um,UO_0000065,,19.9526
102795,,Inconclusive,4994879,[],CHEMBL1614146,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.93,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,Potency,nM,,11668.1,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,Potency,um,UO_0000065,,11.6681
102796,,Active,5018790,[],CHEMBL1613923,"PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ]",F,,,BAO_0000188,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,>,7,1,>,,EC50,nM,,50000.0,CHEMBL612545,,Unchecked,,,,EC50,um,UO_0000065,,50.0
102797,,,5139662,[],CHEMBL1648149,Inhibition of cobalt chloride-induced HIF-1 activation expressed in mouse NIH3T3 cells after 8 hrs by luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1641537,Bioorg Med Chem Lett,2011.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1320419,>,1,1,>,,IC50,nM,,20000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,20.0
102798,,,5139684,[],CHEMBL1648151,Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability after 8 hrs,A,,,BAO_0001103,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1641537,Bioorg Med Chem Lett,2011.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,1320419,<,1,0,<,,Activity,%,,5.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,5.0
102799,,inconclusive,5344746,[],CHEMBL1613818,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",F,P04062,N409S,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,8912.5,CHEMBL2179,Homo sapiens,Beta-glucocerebrosidase,9606.0,,,Potency,uM,UO_0000065,,8.9125
102800,,inconclusive,5426929,[],CHEMBL1738184,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,29092.9,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,29.0929
102801,,inconclusive,5553660,[],CHEMBL1738132,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,39810.7,CHEMBL4096,Homo sapiens,Cellular tumor antigen p53,9606.0,,,Potency,uM,UO_0000065,,39.8107
102802,,inconclusive,5576852,[],CHEMBL1737902,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355]",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,25118.9,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,25.1189
102803,,inconclusive,5652520,[],CHEMBL1738317,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,16353.5,CHEMBL1741209,Homo sapiens,ATPase family AAA domain-containing protein 5,9606.0,,,Potency,uM,UO_0000065,,16.3535
102804,,inconclusive,5884661,[],CHEMBL1738588,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,18348.9,CHEMBL1741209,Homo sapiens,ATPase family AAA domain-containing protein 5,9606.0,,,Potency,uM,UO_0000065,,18.3489
102805,,inconclusive,6472691,[],CHEMBL1794359,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273],F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,50118.7,CHEMBL3885594,Homo sapiens,Importin subunit beta-1/Snurportin-1,9606.0,,,Potency,uM,UO_0000065,,50.1187
102806,,inactive,7147510,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,6573.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,6.5733
102807,,active,7425699,[],CHEMBL1794352,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,2685.5,CHEMBL5567,Photinus pyralis,Luciferin 4-monooxygenase,7054.0,,,Potency,uM,UO_0000065,,2.6855
102808,,inconclusive,7501850,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,28183.8,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,28.1838
102809,,inconclusive,10427559,[],CHEMBL1963937,PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,15848.9,CHEMBL1741167,Trypanosoma brucei brucei,"Phosphoglycerate kinase, glycosomal",5702.0,,,Potency,uM,UO_0000065,,15.8489
102810,,,10893906,[],CHEMBL2033941,Antidiabetic activity in mouse 3T3L1 cells assessed as decrease in glucose consumption from cell culture medium using 450 mg/dL D-glucose at 30 ug/mL after 24 hrs (Rvb = 310 +/- 4 mg/dl),F,,,BAO_0000181,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2029201,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MilligramPerDeciliter,1642582,=,1,0,=,,Activity,mg/dl,,263.0,CHEMBL614510,Mus musculus,3T3-L1,10090.0,,,Activity,mg/dl,,,263.0
102811,,,10940101,[],CHEMBL2049761,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 102.4 mg/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Millimeter,1654832,=,1,1,=,,IZ,mm,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,10.0
102812,,,10940164,[],CHEMBL2049820,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1654832,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
102813,,,10940175,[],CHEMBL2049813,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 43300 at 102.4 mg/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Millimeter,1654832,=,1,1,=,,IZ,mm,,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,9.0
102814,,,10940185,[],CHEMBL2049821,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1654832,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
102815,,,10940203,[],CHEMBL2049823,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic ciprofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,1654832,=,1,0,=,,FICI,,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.31
102816,,,10940204,[],CHEMBL2049825,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic Doxycycline,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,1654832,=,1,0,=,,FICI,,,0.62,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.62
102817,,,10940205,[],CHEMBL2049826,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic ciprofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL2046424,Bioorg Med Chem Lett,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,1654832,=,1,0,=,,FICI,,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.25
102818,,inconclusive,11321502,[],CHEMBL2114843,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,29092.9,CHEMBL1293278,Homo sapiens,Geminin,9606.0,,,Potency,uM,UO_0000065,,29.0929
102819,,inconclusive,11823711,[],CHEMBL2114807,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,22387.2,CHEMBL5990,Homo sapiens,Breast cancer type 1 susceptibility protein,9606.0,,,Potency,uM,UO_0000065,,22.3872
102820,,inconclusive,11832812,[],CHEMBL2114810,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,7079.5,CHEMBL4377,Homo sapiens,"Guanine nucleotide-binding protein G(s), subunit alpha",9606.0,,,Potency,uM,UO_0000065,,7.0795
102821,,active,11926378,[],CHEMBL2114836,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,50118.7,CHEMBL2146310,Human immunodeficiency virus 1,Aberrant vpr protein,11676.0,,,Potency,uM,UO_0000065,,50.1187
102822,,inconclusive,11970448,[],CHEMBL2114916,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,19952.6,CHEMBL2146316,Trypanosoma brucei brucei (strain 927/4 GUTat10.1),Putative uncharacterized protein,999953.0,,,Potency,uM,UO_0000065,,19.9526
102823,,inconclusive,11993880,[],CHEMBL2114908,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,15848.9,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,15.8489
102824,,,12413108,[],CHEMBL3068419,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa 630266,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,>,1,1,>,,MIC,ug.mL-1,,1000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1000.0
102825,,,12413114,[],CHEMBL3068422,Antibacterial activity against multidrug-resistant Klebsiella pneumoniae 626238,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,>,1,1,>,,MIC,ug.mL-1,,1000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1000.0
102826,,,12413116,[],CHEMBL3068423,Antibacterial activity against multidrug-resistant Klebsiella pneumoniae 626511,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,>,1,1,>,,MIC,ug.mL-1,,1000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1000.0
102827,,,12413159,[],CHEMBL3068426,Antibacterial activity against multidrug-resistant Enterococcus faecium 609205,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,315.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,315.0
102828,,,12413168,[],CHEMBL3068418,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa 710218,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,158.0
102829,,,12413169,[],CHEMBL3068420,Antibacterial activity against multidrug-resistant Acinetobacter baumannii B-8 303211,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,158.0
102830,,,12413170,[],CHEMBL3068421,Antibacterial activity against multidrug-resistant Acinetobacter baumannii B-5 302234,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,158.0
102831,,,12413171,[],CHEMBL3068424,Antibacterial activity against multidrug-resistant Escherichia coli 629247,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,158.0
102832,,,12413172,[],CHEMBL3068425,Antibacterial activity against multidrug-resistant Escherichia coli 629119,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,158.0
102833,,,12413173,[],CHEMBL3068427,Antibacterial activity against multidrug-resistant Enterococcus faecalis 609230,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,158.0
102834,,,12413174,[],CHEMBL3068428,Antibacterial activity against multidrug-resistant Staphylococcus epidermidis 619083,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,158.0
102835,,,12413175,[],CHEMBL3068429,Antibacterial activity against multidrug-resistant Staphylococcus epidermidis 620206,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,158.0
102836,,,12413176,[],CHEMBL3068430,Antibacterial activity against multidrug-resistant Staphylococcus aureus 701219,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,158.0
102837,,,12413177,[],CHEMBL3068431,Antibacterial activity against multidrug-resistant Staphylococcus aureus 701230,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,158.0
102838,,,12413178,[],CHEMBL3068432,Antibacterial activity against multidrug-resistant Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,158.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,158.0
102839,,,12413180,[],CHEMBL3068417,Antibacterial activity against Staphylococcus aureus after 24 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1797423,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,125.0
102840,,,12413227,[],CHEMBL3068434,Cytotoxicity against Homo sapiens (human) HT-29 cells after 72 hr by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.61,0,http://www.openphacts.org/units/Nanomolar,1797423,=,1,1,=,,IC50,nM,,24600.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,uM,UO_0000065,,24.6
102841,,,12413243,[],CHEMBL3068433,Cytotoxicity against Homo sapiens (human) SGC7901 cells after 72 hr by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3044877,Med Chem Res,2012.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.86,0,http://www.openphacts.org/units/Nanomolar,1797423,=,1,1,=,,IC50,nM,,13740.0,CHEMBL614909,Homo sapiens,SGC-7901,9606.0,,,IC50,uM,UO_0000065,,13.74
102842,,,12422350,[],CHEMBL3051393,"Anti-inflammatory activity in Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 25 mg/kg, po administered 1 hr before carrageenan challenge measured after 3 hr",F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3046175,Med Chem Res,2011.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,1793447,=,1,1,=,,Inhibition,%,,0.165,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,INH,%,UO_0000187,,0.165
102843,,inconclusive,12824006,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,1143128,,7,1,,,Potency,nM,,32642.7,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,32.6427
102844,,active,14127373,[],CHEMBL3215096,PubChem BioAssay. C. difficile toxins: Counterscreen in absence of substrate UDPG Measured in Biochemical System Using Plate Reader - 7074-02_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000217,biochemical format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.0,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,AC50,nM,,9920.0,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,9.92
102845,,active,14445516,[],CHEMBL3214965,PubChem BioAssay. C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000217,biochemical format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL1201862,,,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.71,0,http://www.openphacts.org/units/Nanomolar,1143128,=,7,1,=,,AC50,nM,,19290.0,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,19.29
102846,,,14671050,[],CHEMBL3269909,Inhibition of NF-kappaB transactivation in TNF-alpha-stimulated human K562 cells preincubated for 2 hrs followed by TNF-alpha challenge measured after 6 hrs by dual luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3259651,Bioorg Med Chem,2014.0,"{'bei': '20.60', 'le': '0.37', 'lle': '1.33', 'sei': '12.39'}",CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.62,0,http://www.openphacts.org/units/Nanomolar,2103870,=,1,1,=,,IC50,nM,,24000.0,CHEMBL2094258,Homo sapiens,Nuclear factor NF-kappa-B complex,9606.0,,,IC50,uM,UO_0000065,,24.0
102847,,,15698361,[],CHEMBL3614969,Anti-leishmanial activity against Leishmania major,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3611995,Eur J Med Chem,2015.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.4,0,http://www.openphacts.org/units/Nanomolar,2498902,=,1,1,=,,IC50,nM,,4000.0,CHEMBL612879,Leishmania major,Leishmania major,5664.0,,,IC50,uM,UO_0000065,,4.0
102848,,,16436652,[],CHEMBL3757148,Antioxidant activity assessed as DPPH radical scavenging activity by measuring remaining DPPH level at 20 uM after 30 mins by plate reader analysis,P,,,BAO_0001103,BAO_0000100,small-molecule physicochemical format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3751756,Bioorg Med Chem,2016.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,2744962,=,1,0,=,,Activity,%,,-9.1,CHEMBL2362975,,No relevant target,,,,Activity,%,UO_0000187,,-9.1
102849,,,16437842,[],CHEMBL3757147,Inhibition of bovine xanthine oxidase assessed as conversion of xanthine to uric acid by spectroscopic analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3751756,Bioorg Med Chem,2016.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,2744962,=,1,1,=,,IC50,nM,,290000.0,CHEMBL3649,Bos taurus,Xanthine dehydrogenase,9913.0,,,IC50,uM,UO_0000065,,290.0
102850,,,16437866,[],CHEMBL3757149,Cytoprotective activity against amyloid beta-induced oxidative stress in mouse Neuro2a cells assessed as cell viability at 250 uM after 6 hrs by MTT assay,F,,,BAO_0001103,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL3751756,Bioorg Med Chem,2016.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,2744962,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
102851,,,18204083,[],CHEMBL4044308,Inhibition of bovine milk xanthine oxidase pre-incubated for 30 mins followed by xanthine addition and measured every 30 secs for 5 mins by spectrophotometry,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4043097,Bioorg Med Chem Lett,2017.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3020118,=,1,1,=,,IC50,nM,,159000.0,CHEMBL3649,Bos taurus,Xanthine dehydrogenase,9913.0,,,IC50,uM,UO_0000065,,159.0
102852,,,18204106,[],CHEMBL4044311,Antioxidant activity assessed as ABTS free radical scavenging activity by measuring trolox equivalents after 6 mins,F,,,BAO_0000181,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4043097,Bioorg Med Chem Lett,2017.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3020118,<,1,0,<,,Activity,mmolequiv/mmol,,0.1,CHEMBL2362975,,No relevant target,,,,Activity,mmolequiv/mmol,,,0.1
102853,,,18204126,[],CHEMBL4044312,Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins at 2000 uM,F,,,BAO_0000201,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4043097,Bioorg Med Chem Lett,2017.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,3020118,=,1,1,=,,Inhibition,%,,25.7,CHEMBL2362975,,No relevant target,,,,INH,%,UO_0000187,,25.7
102854,,,19209160,[],CHEMBL4392929,Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis,A,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3206178,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4295835,Homo sapiens,Thiosulfate sulfurtransferase,9606.0,,,IC50,uM,UO_0000065,,100.0
102855,,,19209218,[],CHEMBL4392928,Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis,A,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3206178,>,1,1,>,,IC50,nM,,63000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,63.0
102856,,,19209295,[],CHEMBL4392934,Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,"{'bei': '19.61', 'le': '0.35', 'lle': '1.11', 'sei': '11.79'}",CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.4,0,http://www.openphacts.org/units/Nanomolar,3206178,=,1,1,=,,IC50,nM,,40000.0,CHEMBL4106139,Escherichia coli,GroEL/GroES,562.0,,,IC50,uM,UO_0000065,,40.0
102857,,,19209353,[],CHEMBL4392935,Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,"{'bei': '20.86', 'le': '0.38', 'lle': '1.39', 'sei': '12.54'}",CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.68,0,http://www.openphacts.org/units/Nanomolar,3206178,=,1,1,=,,IC50,nM,,21000.0,CHEMBL4106139,Escherichia coli,GroEL/GroES,562.0,,,IC50,uM,UO_0000065,,21.0
102858,,,19209411,[],CHEMBL4392933,Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 40 to 60 mins by malachite green dye based spectrometric analysis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,"{'bei': '20.77', 'le': '0.37', 'lle': '1.37', 'sei': '12.49'}",CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.66,0,http://www.openphacts.org/units/Nanomolar,3206178,=,1,1,=,,IC50,nM,,22000.0,CHEMBL4106131,Homo sapiens,HSP60/HSP10,9606.0,,,IC50,uM,UO_0000065,,22.0
102859,,,19209469,[],CHEMBL4392931,Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3206178,>,1,1,>,,IC50,nM,,250000.0,CHEMBL4296299,Escherichia coli (strain K12),60 kDa chaperonin,83333.0,,,IC50,uM,UO_0000065,,250.0
102860,,,19209511,[],CHEMBL4392932,"Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis",B,,,BAO_0000179,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3206178,=,1,0,=,,Ratio IC50,,,1.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,10.0,1.0
102861,,,19209541,[],CHEMBL4392930,"Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis",B,,,BAO_0000179,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3206178,=,1,0,=,,Ratio IC50,,,1.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,10.0,1.0
102862,,,19209571,[],CHEMBL4392936,"Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis",B,,,BAO_0000179,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3206178,=,1,0,=,,Ratio IC50,,,1.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,10.0,1.0
102863,,,19209601,[],CHEMBL4392937,"Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis",B,,,BAO_0000179,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3206178,=,1,0,=,,Ratio IC50,,,1.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,10.0,1.0
102864,,,19209647,[],CHEMBL4392939,Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis relative to untreated control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,3206178,=,1,1,=,,Inhibition,%,,66.0,CHEMBL4106139,Escherichia coli,GroEL/GroES,562.0,,,INH,%,UO_0000187,,66.0
102865,,,19209797,[],CHEMBL4392938,Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis relative to untreated control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4392822,Bioorg Med Chem Lett,2019.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://qudt.org/vocab/unit#Percent,3206178,=,1,1,=,,Inhibition,%,,98.0,CHEMBL4106139,Escherichia coli,GroEL/GroES,562.0,,,INH,%,UO_0000187,,98.0
102866,,Non-Toxic,22764947,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4703053,Effect on cell viability in human neutrophils assessed as decrease in cell viability at 50 uM after 1 hr by Propidium staining based flow cytometric analysis,A,,,BAO_0000375,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4699537,J Nat Prod,2020.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3534015,,1,0,,,Activity,,,,CHEMBL5314326,Homo sapiens,Neutrophil,9606.0,,,Activity,,,,
102867,,,22764983,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': '<=30', 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': None, 'text_value': '<=30', 'type': 'Time', 'units': 'min', 'value': None}]",CHEMBL4703059,Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 5.5 mM glucose by luminol-amplified chemiluminescence method,F,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4699537,J Nat Prod,2020.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,5.06,0,http://www.openphacts.org/units/Nanomolar,3534015,=,1,1,=,,IC50,nM,,8800.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,8.8
102868,,,22765007,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': '<=30', 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': None, 'text_value': '<=30', 'type': 'Time', 'units': 'min', 'value': None}]",CHEMBL4703064,Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 30 mM glucose by luminol-amplified chemiluminescence method,F,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL4699537,J Nat Prod,2020.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.94,0,http://www.openphacts.org/units/Nanomolar,3534015,=,1,1,=,,IC50,nM,,11600.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,11.6
102869,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870344,[],CHEMBL5152971,Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.7,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,IC50,nM,,20000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,20.0
102870,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870365,[],CHEMBL5152972,Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dRho refolding by reporter analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.41,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,IC50,nM,,39000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,39.0
102871,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870386,[],CHEMBL5152973,Inhibition of human mitochondrial HSP60 expressed in Escherichia coli Rosetta 2 (DE3) cells/human mitochondrial HSP10 expressed in Escherichia coli Rosetta 2 (DE3) pLysS cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis,B,,,BAO_0000190,BAO_0000252,mitochondrion format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.68,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,IC50,nM,,21000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,21.0
102872,,,24870407,[],CHEMBL5152974,Inhibition of refolded rhodanese reporter enzyme (unknown origin),B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3886553,>,1,1,>,,IC50,nM,,100000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,100.0
102873,,,24870428,[],CHEMBL5152975,Inhibition of refolded MDH reporter enzyme (unknown origin),B,,,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3886553,>,1,1,>,,IC50,nM,,63000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,63.0
102874,,,24870449,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152976,Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,F,,,BAO_0000188,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.5,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,EC50,nM,,32000.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,EC50,uM,UO_0000065,,32.0
102875,,,24870470,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152977,Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,F,,,BAO_0000188,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.29,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,EC50,nM,,51000.0,CHEMBL614285,Homo sapiens,DLD-1,9606.0,,,EC50,uM,UO_0000065,,51.0
102876,,,24870491,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152978,Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,F,,,BAO_0000188,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.41,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,EC50,nM,,39000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,EC50,uM,UO_0000065,,39.0
102877,,,24870512,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152979,Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,F,,,BAO_0000188,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,4.5,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,EC50,nM,,32000.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,EC50,uM,UO_0000065,,32.0
102878,,,24870533,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152980,Cytotoxicity against human FHs74Int cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,T,,,BAO_0000187,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3886553,=,1,1,=,,CC50,nM,,97000.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,97.0
102879,,,24870554,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5152981,Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay,T,,,BAO_0000187,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,http://www.openphacts.org/units/Nanomolar,3886553,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614654,Homo sapiens,FHC,9606.0,,,CC50,uM,UO_0000065,,100.0
102880,,,24870572,[],CHEMBL5152982,"Selectivity index, ratio of CC50 for cytotoxicity against non-cancerous cells to EC50 for cytotoxicity against human HCT-116 cells",T,,,BAO_0000179,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,,,CHEMBL5150040,Bioorg Med Chem,2022.0,,CHEMBL7747,4-HYDROXYCHALCONE,CHEMBL7747,,0,,3886553,=,1,0,=,,Ratio CC50/EC50,,,3.1,CHEMBL612545,,Unchecked,,,,Ratio CC50/EC50,,,,3.1
102881,,,266728,[],CHEMBL673430,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of 1*10e-6 M,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,28301,=,1,1,=,,Inhibition,%,,85.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Inhibition,%,UO_0000187,,85.8
102882,,,266729,[],CHEMBL673433,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of at 1*10e-5 M,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,28301,=,1,1,=,,Inhibition,%,,66.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Inhibition,%,UO_0000187,,66.5
102883,,,266730,[],CHEMBL673429,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of 1*10e-4 M,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,28301,=,1,1,=,,Inhibition,%,,45.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Inhibition,%,UO_0000187,,45.3
102884,,,266731,[],CHEMBL673432,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of at 1*10e-3 M,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,28301,=,1,1,=,,Inhibition,%,,28.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Inhibition,%,UO_0000187,,28.0
102885,,,266732,[],CHEMBL858605,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in staphylococcus aureus at the Upjohn culture 76,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
102886,,,266733,[],CHEMBL795169,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in staphylococcus aureus at the Upjohn culture 6685,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,>,1,1,>,,MIC,ug.mL-1,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,400.0
102887,,,266734,[],CHEMBL795170,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in staphylococcus aureus at the Upjohn culture 6690,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
102888,,,266735,[],CHEMBL857929,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Enterococcus faecalis at the Upjohn culture,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,50.0
102889,,,266736,[],CHEMBL801923,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Streptococcus pyogenes at the Upjohn culture,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
102890,,,266737,[],CHEMBL799755,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Streptococcus pneumoniae at the Upjohn culture,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.78
102891,,,266738,[],CHEMBL671301,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Escherichia coli at the Upjohn culture,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,>,1,1,>,,MIC,ug.mL-1,,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,400.0
102892,,,266739,[],CHEMBL702896,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Klebsiella pneumoniae at the Upjohn culture,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,=,1,1,=,,MIC,ug.mL-1,,400.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,400.0
102893,,,266740,[],CHEMBL802777,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Salmonella schottmuelleri,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,>,1,1,>,,MIC,ug.mL-1,,800.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,800.0
102894,,,266741,[],CHEMBL755260,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Pseudomonas aeruginosa at the Upjohn culture 95,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,>,1,1,>,,MIC,ug.mL-1,,400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,400.0
102895,,,266742,[],CHEMBL755259,The compound was tested for minimum inhibitory concentration required for inhibition of microbial growth in Pseudomonas aeruginosa at the Upjohn culture 6676,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1126976,J Med Chem,1993.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,28301,>,1,1,>,,MIC,ug.mL-1,,400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,400.0
102896,,,1090293,[],CHEMBL628290,Calculated membrane partition coefficient (Kmemb),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1149124,J Med Chem,2004.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,85138,=,1,0,=,,Log Kmemb,,,-1.8,CHEMBL2362975,,No relevant target,,,,Log Kmemb,,,,-1.8
102897,,Not Evaluated,1819458,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
102898,,Not Evaluated,1829198,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL612582,,Osteoblast,,,,Activity,,,,
102899,,Not Evaluated,1829234,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,Activity,,,,
102900,,Not Evaluated,1829235,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,Activity,,,,
102901,,Not Evaluated,1829236,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL399,Homo sapiens,HeLa,9606.0,,,Activity,,,,
102902,,Not Evaluated,1829237,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,625759,,1,0,,,Activity,,,,CHEMBL399,Homo sapiens,HeLa,9606.0,,,Activity,,,,
102903,,,1866404,[],CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/Nanomolar,634685,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
102904,,,1866433,[],CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/Nanomolar,634685,=,1,1,=,,MIC,nM,,103600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,103.6
102905,,,1866462,[],CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/Nanomolar,634685,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
102906,,,1866491,[],CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/Nanomolar,634685,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
102907,,,2500074,[],CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779730,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC50,ug ml-1,UO_0000274,,0.5
102908,,,2500080,[],CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779730,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC50,ug ml-1,UO_0000274,,1.0
102909,,,2500081,[],CHEMBL1016074,Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779730,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC,ug ml-1,UO_0000274,,1.0
102910,,,2500082,[],CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779730,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC90,ug ml-1,UO_0000274,,1.0
102911,,,2500088,[],CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779730,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC90,ug ml-1,UO_0000274,,2.0
102912,,Not Active,2590834,[],CHEMBL965581,Inhibition of bovine liver MAOA,B,,,BAO_0000375,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,725748,,1,0,,,Activity,,,,CHEMBL3254,Bos taurus,Monoamine oxidase A,9913.0,,,Activity,,,,
102913,,Not Active,2590852,[],CHEMBL965583,Inhibition of bovine liver MAOB,B,,,BAO_0000375,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,725748,,1,0,,,Activity,,,,CHEMBL2756,Bos taurus,Monoamine oxidase B,9913.0,,,Activity,,,,
102914,,,3216094,[],CHEMBL1100460,"Dissociation constant, pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,898726,=,1,0,=,,pKa,,,7.65,CHEMBL2362975,,No relevant target,,,,pKa,,,,7.65
102915,,,3216185,[],CHEMBL1100461,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,898726,=,1,0,=,,logFu,,,0.28,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,logFu,,,,0.28
102916,,,3217412,[],CHEMBL1100462,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,898726,=,1,1,=,,Vdss,L.kg-1,,1.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,1.3
102917,,,3264708,[],CHEMBL1116254,Human intestinal absorption in po dosed human,A,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1157012,Eur J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,906051,=,1,0,=,,Activity,%,,0.28,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,0.28
102918,,,3282171,[],CHEMBL1112933,Transcellular permeability at pH 6.5 calculated from in vitro P app values in Caco-2 and/or MDCK cells,A,,,BAO_0000179,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1158536,J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,910090,=,1,0,=,,logPapp,,,-7.76,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,logPapp,,,,-7.76
102919,,,3282235,[],CHEMBL1112930,Absolute bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1158536,J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,910090,=,1,1,=,,F,%,,25.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,25.0
102920,,,3388257,[],CHEMBL1216115,"Antimicrobial activity against erythromycin, lincomycin, clindamycin resistant Staphylococcus haemolyticus isolate 134PL harboring ermC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,32.0
102921,,,3388258,[],CHEMBL1216116,"Antimicrobial activity against erythromycin, lincomycin, clindamycin resistant Staphylococcus epidermidis isolate 44KR harboring ermC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
102922,,,3388259,[],CHEMBL1216117,"Antimicrobial activity against erythromycin, inducible lincomycin, inducible clindamycin resistant Staphylococcus haemolyticus isolate 31UL harboring ermC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,1.0
102923,,,3388260,[],CHEMBL1216118,"Antimicrobial activity against erythromycin, inducible lincomycin, inducible clindamycin resistant Staphylococcus epidermidis isolate 32PL harboring ermC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
102924,,,3388261,[],CHEMBL1216119,"Antimicrobial activity against lincomycin, clindamycin resistant Staphylococcus haemolyticus isolate 29OL harboring vgaALC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,64.0
102925,,,3388262,[],CHEMBL1216120,Antimicrobial activity against lincomycin resistant Staphylococcus haemolyticus isolate 123PL harboring lnuA gene incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,128.0
102926,,,3388263,[],CHEMBL1216121,Antimicrobial activity against lincomycin resistant Staphylococcus epidermidis isolate 102OL harboring lnuA gene incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
102927,,,3388264,[],CHEMBL1216122,Antimicrobial activity against erythromycin resistant Staphylococcus haemolyticus isolate 202BB harboring msrA gene incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,1.0
102928,,,3388265,[],CHEMBL1216123,Antimicrobial activity against erythromycin resistant Staphylococcus epidermidis isolate 129OV harboring msrA gene incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
102929,,,3388266,[],CHEMBL1216124,"Antimicrobial activity against erythromycin, lincomycin, clindamycin resistant Staphylococcus haemolyticus isolate 65OL harboring ermC vgaALC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,128.0
102930,,,3388267,[],CHEMBL1216125,"Antimicrobial activity against erythromycin, lincomycin, clindamycin resistant Staphylococcus epidermidis isolate 1036UL harboring ermC vgaALC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
102931,,,3388268,[],CHEMBL1216126,"Antimicrobial activity against erythromycin, lincomycin resistant Staphylococcus haemolyticus isolate 113OL harboring msrA lnuA gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,128.0
102932,,,3388269,[],CHEMBL1216127,"Antimicrobial activity against erythromycin, lincomycin, clindamycin resistant Staphylococcus epidermidis isolate 32OL harboring msrA lnuA vgaALC gene incubated at 37 degC for 24 hrs by agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
102933,,,3388270,[],CHEMBL1216128,Antimicrobial activity against Staphylococcus aureus isolate CIP 107907 harboring vgaA gene incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
102934,,,3388271,[],CHEMBL1216129,Antimicrobial activity against Staphylococcus aureus ATCC 29213 incubated at 37 degC for 24 hrs by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1212782,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929586,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102935,,,3494940,[],CHEMBL1262999,Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,128.0
102936,,,3494952,[],CHEMBL1263000,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,64.0
102937,,,3494964,[],CHEMBL1263830,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,64.0
102938,,,3494976,[],CHEMBL1263954,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,256.0
102939,,,3494988,[],CHEMBL1263955,Antimicrobial activity against aheB-deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,256.0
102940,,,3495000,[],CHEMBL1263956,Antimicrobial activity against Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,1024.0
102941,,,3495012,[],CHEMBL1263957,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,64.0
102942,,,3495024,[],CHEMBL1263958,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AcrAB efflux pump by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,>,1,1,>,,MIC,ug.mL-1,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,1024.0
102943,,,3495036,[],CHEMBL1263959,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AheABC efflux pump by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,512.0
102944,,,3495048,[],CHEMBL1263960,Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1255307,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960378,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,128.0
102945,,Not Active,3539242,[],CHEMBL1285392,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,B,,,BAO_0000375,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,971020,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
102946,,Not Active,3539327,[],CHEMBL1285394,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,B,,,BAO_0000375,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,971020,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
102947,,,3539393,[],CHEMBL1285395,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Millimeter,971020,=,1,1,=,,IZ,mm,,0.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,IZ,cm,UO_0000016,,0.0
102948,,,3539459,[],CHEMBL1285393,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Millimeter,971020,=,1,1,=,,IZ,mm,,0.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,IZ,cm,UO_0000016,,0.0
102949,,,3542911,[],CHEMBL1284925,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
102950,,,3542912,[],CHEMBL1284926,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid VGA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
102951,,,3542913,[],CHEMBL1284927,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid CU1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
102952,,,3542914,[],CHEMBL1284928,Antimicrobial activity against Staphylococcus aureus RN4220 harboring vgaAv positive plasmid CU1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
102953,,,3542915,[],CHEMBL1284929,Antimicrobial activity against Staphylococcus aureus RN1024,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
102954,,,3542916,[],CHEMBL1284930,Antimicrobial activity against Staphylococcus aureus RN1024-tms,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102955,,,3542917,[],CHEMBL1284931,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970523,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102956,,,3548414,[],CHEMBL1283848,Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970745,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,100.0
102957,,,3548415,[],CHEMBL1283849,Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970745,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,25.0
102958,,,3548416,[],CHEMBL1283850,Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970745,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,25.0
102959,,,3548417,[],CHEMBL1283851,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm0527,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,970745,=,1,0,=,,Ratio,,,4.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Ratio,,,,4.0
102960,,,3548418,[],CHEMBL1283852,Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970745,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,100.0
102961,,,3548419,[],CHEMBL1283853,Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970745,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,50.0
102962,,,3548420,[],CHEMBL1283854,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm1980,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1275542,Antimicrob Agents Chemother,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,970745,=,1,0,=,,Ratio,,,1.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Ratio,,,,1.0
102963,,,5079487,[],CHEMBL1614672,Fraction unbound in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1310764,=,1,1,=,,Fu,,,0.14,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fu,,,,0.14
102964,,,5080933,[],CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1310764,=,1,1,=,,Vdss,L.kg-1,,1.0,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,1.0
102965,,,5081580,[],CHEMBL1614671,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1310764,=,1,1,=,,CL,mL.min-1.kg-1,,2.1,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,2.1
102966,,,5082441,[],CHEMBL1614674,Half life in human after iv administration,A,,,BAO_0002115,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Hour,1310764,=,1,1,=,,T1/2,hr,,5.6,CHEMBL612558,,ADMET,,,,t1/2,h,UO_0000032,,5.6
102967,,,5082664,[],CHEMBL1614673,Mean residence time in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Hour,1310764,=,1,1,=,,MRT,hr,,7.5,CHEMBL612558,,ADMET,,,,MRT,h,UO_0000032,,7.5
102968,,,5085391,[],CHEMBL1634296,Antimicrobial activity against Streptomyces coelicolor 1147 after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,50.0
102969,,,5085400,[],CHEMBL1634297,Antimicrobial activity against streptomycin-resistant Streptomyces coelicolor KO-178 harboring rpsL K88E mutant gene after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,40.0
102970,,,5085409,[],CHEMBL1634298,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor KO-347 harboring rpsl P91S mutant gene after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,50.0
102971,,,5085418,[],CHEMBL1634299,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor 92G harboring rpsL gene with inserted glycine at position 92 after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,20.0
102972,,,5085427,[],CHEMBL1634300,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP1 harboring rpsL A262G and C271T mutant gene after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,40.0
102973,,,5085436,[],CHEMBL1634449,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP2 harboring rpsL K88E mutant gene and inserted glycine at position 92 of the gene after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315535,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,,MIC,ug ml-1,UO_0000274,,10.0
102974,,,5148546,[],CHEMBL1661505,Antimicrobial activity against Staphylococcus aureus CIP 76.25 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325690,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
102975,,,5148547,[],CHEMBL1661504,Antimicrobial activity against Staphylococcus aureus CIP 76.25 by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102976,,,5148548,[],CHEMBL1661503,Antimicrobial activity against Staphylococcus aureus CIP 76.25 by microdilution method in presence of 4% human serum albumin,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102977,,,5148549,[],CHEMBL1661502,Antimicrobial activity against Staphylococcus aureus CIP 76.25 by microdilution method in presence of 0.1% alpha-1-acid glycoprotein,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
102978,,,5148550,[],CHEMBL1661506,Antimicrobial activity against Staphylococcus aureus CIP 76.25 by microdilution method in presence of 1.6% gamma globulin,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102979,,,5148588,[],CHEMBL1661507,Binding affinity to first site on human serum albumin by SPR,A,,,BAO_0000034,BAO_0000357,single protein format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,4.92,0,http://www.openphacts.org/units/Nanomolar,1325690,=,1,1,=,,Kd,nM,,12000.0,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,Kd,uM,UO_0000065,,12.0
102980,,,5148597,[],CHEMBL1661508,Binding affinity to human alpha-1-acid glycoprotein assessed as compound binding sites level by SPR,A,,,BAO_0000193,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1325690,<,1,0,<,,Ratio,,,1.0,CHEMBL612558,,ADMET,,,,Ratio,,,,1.0
102981,,,5148601,[],CHEMBL1661509,Protein binding in serum,A,,,BAO_0000179,BAO_0000366,cell-free format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://qudt.org/vocab/unit#Percent,1325690,=,1,1,=,,PPB,%,,75.0,CHEMBL612558,,ADMET,,,,PB,%,UO_0000187,,75.0
102982,,,5148611,[],CHEMBL1661514,Binding affinity to human serum albumin assessed as fraction of binding sites occupied by compound at 130 to 180 ug/ml by SPR,A,,,BAO_0000193,BAO_0000357,single protein format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649135,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1325690,=,1,0,=,,Ratio,,,0.5,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,Ratio,,,,0.5
102983,,,5170280,[],CHEMBL1663502,Drug absorption in human assessed as human intestinal absorption rate,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649380,Eur J Med Chem,2011.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1325486,=,1,0,=,,log10(%HIA +10),,,1.574,CHEMBL612558,,ADMET,,,,log10(%HIA +10),,,,1.574
102984,,,5181197,[],CHEMBL1667245,Antibacterial activity against Staphylococcus aureus RN4220 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327079,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102985,,,5181198,[],CHEMBL1667246,"Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD, tet(L), dfrK and vga(C) gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327079,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
102986,,,5181199,[],CHEMBL1667247,"Antibacterial activity against Staphylococcus aureus RN4220 harboring tet(L), dfrK gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327079,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102987,,,5181200,[],CHEMBL1667248,Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD and tet(L) gene by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327079,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
102988,,,5296345,[],CHEMBL1691262,Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338210,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,125.0
102989,,,5296362,[],CHEMBL1691263,Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338210,=,1,1,=,,MIC,ug.mL-1,,31.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,31.25
102990,,,5296379,[],CHEMBL1691264,Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP72,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338210,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
102991,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748772,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102992,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748773,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
102993,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748774,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102994,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748775,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
102995,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748776,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102996,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748777,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
102997,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748778,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
102998,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748779,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
102999,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748780,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
